P.3.d.013 Off-label use of second generation antipsychotics in psychiatric inpatients: data from the AMSP study group (Englisch)
- Neue Suche nach: Konstantinidis, A.
- Neue Suche nach: Kutzelnigg, A.
- Neue Suche nach: Moser, U.
- Neue Suche nach: Grohmann, R.
- Neue Suche nach: Jaquenoud Sirot, E.
- Neue Suche nach: Engel, R.
- Neue Suche nach: Kasper, S.
- Neue Suche nach: Konstantinidis, A.
- Neue Suche nach: Kutzelnigg, A.
- Neue Suche nach: Moser, U.
- Neue Suche nach: Grohmann, R.
- Neue Suche nach: Jaquenoud Sirot, E.
- Neue Suche nach: Engel, R.
- Neue Suche nach: Kasper, S.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
18
;
S455-S456
;
2008
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:P.3.d.013 Off-label use of second generation antipsychotics in psychiatric inpatients: data from the AMSP study group
-
Beteiligte:Konstantinidis, A. ( Autor:in ) / Kutzelnigg, A. ( Autor:in ) / Moser, U. ( Autor:in ) / Grohmann, R. ( Autor:in ) / Jaquenoud Sirot, E. ( Autor:in ) / Engel, R. ( Autor:in ) / Kasper, S. ( Autor:in )
-
Erschienen in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 18 ; S455-S456
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2008
-
Format / Umfang:S455-S456
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.8 / 615.1
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 18
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Attenuated disruption of prepulse inhibition by dopaminergic stimulation after maternal deprivation and adolescent corticosterone treatment in ratsChoy, K. H. / van den Buuse, M. et al. | 2008
- 14
-
Bright light exposure during acute tryptophan depletion prevents a lowering of mood in mildly seasonal womenaan het Rot, M. / Benkelfat, C. / Boivin, D. B. / Young, S. N. et al. | 2008
- 24
-
The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid productionDanovich, L. / Veenman, L. / Leschiner, S. / Lahav, M. / Shuster, V. / Weizman, A. / Gavish, M. et al. | 2008
- 34
-
The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophreniaHamdani, N. / Tabeze, J. P. / Ramoz, N. / Ades, J. / Hamon, M. / Sarfati, Y. / Boni, C. / Gorwood, P. et al. | 2008
- 41
-
Factors triggering abolishment of benzodiazepines effects in the four-plate test–retest in micePetit-Demoulière, B. / Hascoët, M. / Bourin, M. et al. | 2008
- 48
-
Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with Lamotrigine monotherapyHaldane, M. / Jogia, J. / Cobb, A. / Kozuch, E. / Kumari, V. / Frangou, S. et al. | 2008
- 55
-
Specific binding of [3H]Ro 19-6327 (lazabemide) to monoamine oxidase B is increased in frontal cortex of suicide victims after controlling for age at deathBallesteros, J. / Maeztu, A. I. / Callado, L. F. / Meana, J. J. / Gutiérrez, M. et al. | 2008
- 62
-
Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: A systematic review and meta-analysisUsala, T. / Clavenna, A. / Zuddas, A. / Bonati, M. et al. | 2008
- 74
-
Endogenous bufadienolide mediates pressor response to ethanol withdrawal in ratsKashkin, V. A. / Zvartau, E. E. / Fedorova, O. V. / Bagrov, Y. Y. / Lakatta, E. G. / Bagrov, A. Y. et al. | 2008
- 78
-
Calendar of Meetings of the European College ofNeuropsychopharmacology| 2008
- 79
-
CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHDTrzepacz, P. T. / Williams, D. W. / Feldman, P. D. / Wrishko, R. E. / Witcher, J. W. / Buitelaar, J. K. et al. | 2008
- 87
-
Pre-training administration of tianeptine, but not propranolol, protects hippocampus-dependent memory from being impaired by predator stressCampbell, A. M. / Park, C. R. / Zoladz, P. R. / Muñoz, C. / Fleshner, M. / Diamond, D. M. et al. | 2008
- 99
-
Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophreniaMuntjewerff, J. W. / Gellekink, H. / den Heijer, M. / Hoogendoorn, M. L. / Kahn, R. S. / Sinke, R. J. / Blom, H. J. et al. | 2008
- 107
-
The immediate early gene Arc is associated with behavioral resilience to stress exposure in an animal model of posttraumatic stress disorderKozlovsky, N. / Matar, M. A. / Kaplan, Z. / Kotler, M. / Zohar, J. / Cohen, H. et al. | 2008
- 117
-
Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary studyKrivoy, A. / Weizman, A. / Laor, L. / Hellinger, N. / Zemishlany, Z. / Fischel, T. et al. | 2008
- 122
-
A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorderPapakostas, G. I. / Nelson, J. C. / Kasper, S. / Möller, H. J. et al. | 2008
- 128
-
Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathwayPeng, C. H. / Chiou, S. H. / Chen, S. J. / Chou, Y. C. / Ku, H. H. / Cheng, C. K. / Yen, C. J. / Tsai, T. H. / Chang, Y. L. / Kao, C. L. et al. | 2008
- 141
-
Paroxetine with pindolol augmentation: A double-blind, randomized, placebo-controlled study in depressed in-patientsGeretsegger, C. / Bitterlich, W. / Stelzig, R. / Stuppaeck, C. / Bondy, B. / Aichhorn, W. et al. | 2008
- 147
-
Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: Development of a selective α7 nicotinic acetylcholine receptor agonist strategyDeutsch, S. I. / Rosse, R. B. / Schwartz, B. L. / Schooler, N. R. / Gaskins, B. L. / Long, K. D. / Mastropaolo, J. et al. | 2008
- 152
-
Evidence that lithium protects against tardive dyskinesia: The Curaçao Extrapyramidal Syndromes study VIvan Harten, P. N. / Hoek, H. W. / Matroos, G. E. / van Os, J. et al. | 2008
- 156
-
ECNP Calendar of Events| 2008
- 157
-
A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugsLinnet, K. / Ejsing, T. B. et al. | 2008
- 170
-
Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) studyBitter, I. / Treuer, T. / Dyachkova, Y. / Martenyi, F. / McBride, M. / Ungvari, G. S. et al. | 2008
- 181
-
DHEAS repeated treatment improves cognitive and behavioral deficits after mild traumatic brain injuryMilman, A. / Zohar, O. / Maayan, R. / Weizman, R. / Pick, C. G. et al. | 2008
- 188
-
Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT)Peles, E. / Schreiber, S. / Adelson, M. et al. | 2008
- 194
-
Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the midbrainEmmanouil, D. E. / Dickens, A. S. / Heckert, R. W. / Ohgami, Y. / Chung, E. / Han, S. / Quock, R. M. et al. | 2008
- 200
-
In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic propertiesAdage, T. / Trillat, A. C. / Quattropani, A. / Perrin, D. / Cavarec, L. / Shaw, J. / Guerassimenko, O. / Giachetti, C. / Gréco, B. a. / Chumakov, I. et al. | 2008
- 215
-
Effects of cross-sex hormones on cerebral activation during language and mental rotation: An fMRI study in transsexualsSommer, I. E. / Cohen-Kettenis, P. T. / van Raalten, T. / vd Veer, A. J. / Ramsey, L. E. / Gooren, L. J. / Kahn, R. S. / Ramsey, N. F. et al. | 2008
- 222
-
Norchloro-fluoro-homoepibatidine (NCFHEB) — A promising radioligand for neuroimaging nicotinic acetylcholine receptors with PETDeuther-Conrad, W. / Patt, J. T. / Lockman, P. R. / Allen, D. D. / Patt, M. / Schildan, A. / Ganapathy, V. / Steinbach, J. / Sabri, O. / Brust, P. et al. | 2008
- 230
-
A detailed examination of cytokine abnormalities in Major Depressive DisorderSimon, N. M. / McNamara, K. / Chow, C. W. / Maser, R. S. / Papakostas, G. I. / Pollack, M. H. / Nierenberg, A. A. / Fava, M. / Wong, K. K. et al. | 2008
- 235
-
Antidepressant drugs and memory: Insights from animal studiesMonleón, S. / Vinader-Caerols, C. n. / Arenas, M. C. / Parra, A. s. et al. | 2008
- 249
-
Platelet 18 kDa Translocator Protein density is reduced in depressed patients with adult separation anxietyChelli, B. / Pini, S. / Abelli, M. / Cardini, A. / Lari, L. / Muti, M. / Gesi, C. / Cassano, G. B. / Lucacchini, A. / Martini, C. et al. | 2008
- 255
-
Dehydroepiandrosterone and monoamines in the limbic system of a genetic animal model of childhood depressionMalkesman, O. / Braw, Y. / Ram, E. / Maayan, R. / Weizman, A. / Kinor, N. / Yadid, G. / Weller, A. et al. | 2008
- 262
-
Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent malesZijlstra, F. / Booij, J. / van den Brink, W. / Franken, I. H. et al. | 2008
- 271
-
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST)Leggio, G. M. / Micale, V. / Drago, F. et al. | 2008
- 278
-
Cerebral blood flow effects of acute intravenous heroin administrationKosel, M. / Noss, R. S. / Hämmig, R. / Wielepp, P. / Bundeli, P. / Heidbreder, R. / Kinser, J. A. / Brenneisen, R. / Fisch, H. U. / Kayser, S. et al. | 2008
- 286
-
5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleusDos Santos, L. i. / de Andrade, T. G. / Zangrossi, H. l. et al. | 2008
- 295
-
Global DNA methylation is influenced by smoking behaviourHillemacher, T. / Frieling, H. / Moskau, S. / Muschler, M. A. / Semmler, A. / Kornhuber, J. / Klockgether, T. / Bleich, S. / Linnebank, M. et al. | 2008
- 299
-
Guanosine possesses specific modulatory effects on NMDA receptor-mediated neurotransmission in intact miceDeutsch, S. I. / Rosse, R. B. / Long, K. D. / Gaskins, B. L. / Mastropaolo, J. et al. | 2008
- 303
-
α1-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged accessWee, S. / Mandyam, C. D. / Lekic, D. M. / Koob, G. F. et al. | 2008
- 312
-
Hypothalamus volume in twin pairs discordant for schizophreniaKoolschijn, P. C. / van Haren, N. E. / Hulshoff Pol, H. E. / Kahn, R. S. et al. | 2008
- 317
-
Acute tryptophan depletion does not alter central or plasma brain-derived neurotrophic factor in the ratCahir, M. / Ardis, T. C. / Elliott, J. J. / Kelly, C. B. / Reynolds, G. P. / Cooper, S. J. et al. | 2008
- 323
-
Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming testGhasemi, M. / Sadeghipour, H. / Mosleh, A. / Sadeghipour, H. R. / Mani, A. R. / Dehpour, A. R. et al. | 2008
- 333
-
Cerebrospinal fluid d-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patientsFuchs, S. A. / De Barse, M. M. / Scheepers, F. E. / Cahn, W. / Dorland, L. / de Sain-van der Velden, M. G. / Klomp, L. W. / Berger, R. / Kahn, R. S. / de Koning, T. J. et al. | 2008
- 339
-
Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in miceHebb, A. L. / Robertson, H. A. / Denovan-Wright, E. M. et al. | 2008
- 364
-
8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorderMaina, G. / Pessina, E. / Albert, U. / Bogetto, F. et al. | 2008
- 373
-
Time dependent alterations on tyrosine hydroxylase, opioid and cannabinoid CB1 receptor gene expressions after acute ethanol administration in the rat brainOliva, J. M. / Ortiz, S. / Pérez-Rial, S. / Manzanares, J. et al. | 2008
- 383
-
Therapeutic effects of Δ9-THC and modafinil in a marmoset Parkinson modelvan Vliet, S. A. / Vanwersch, R. A. / Jongsma, M. J. / Olivier, B. / Philippens, I. H. et al. | 2008
- 390
-
Psychobiological responses to drug cues before and after methadone intake in heroin-dependent patients: A pilot studyWalter, M. / Wiesbeck, G. A. / Bloch, N. / Aeschbach, S. / Olbrich, H. M. / Seifritz, E. / Dürsteler-MacFarland, K. M. et al. | 2008
- 395
-
The possible involvement of metabotropic glutamate receptors in schizophreniaKrivoy, A. / Fischel, T. / Weizman, A. et al. | 2008
- 406
-
The effect of DHEA complementary treatment on heroin addicts participating in a rehabilitation program: A preliminary studyMaayan, R. / Touati-Werner, D. / Shamir, D. / Yadid, G. / Friedman, A. / Eisner, D. / Weizman, A. / Herman, I. et al. | 2008
- 414
-
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serineHashimoto, K. / Fujita, Y. / Ishima, T. / Chaki, S. / Iyo, M. et al. | 2008
- 422
-
Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: A pooled analysis of 6 studiesStein, D. J. / Baldwin, D. S. / Baldinetti, F. / Mandel, F. et al. | 2008
- 431
-
Relationship between antidepressants and IGF-1 system in the brain: Possible role in cognitionGrunbaum-Novak, N. / Taler, M. / Gil-Ad, I. / Weizman, A. / Cohen, H. / Weizman, R. et al. | 2008
- 439
-
The role of dopamine in alcohol self-administration in humans: Individual differencesBarrett, S. P. / Pihl, R. O. / Benkelfat, C. / Brunelle, C. / Young, S. N. / Leyton, M. et al. | 2008
- 448
-
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: Role of serotonin 5-HT1A receptorsHagiwara, H. / Fujita, Y. / Ishima, T. / Kunitachi, S. / Shirayama, Y. / Iyo, M. / Hashimoto, K. et al. | 2008
- 455
-
Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over studyAmiaz, R. / Fostick, L. / Gershon, A. / Zohar, J. et al. | 2008
- 462
-
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasksMicale, V. / Scapagnini, G. / Colombrita, C. / Mazzola, C. / Alkon, D. L. / Drago, F. et al. | 2008
- 473
-
Imaging the placebo response: A neurofunctional reviewFaria, V. / Fredrikson, M. / Furmark, T. et al. | 2008
- 486
-
Repeated low dose of phencyclidine administration impairs spatial learning in mice: Blockade by clozapine but not by haloperidolBeraki, S. / Kuzmin, A. / Tai, F. / Ögren, S. O. et al. | 2008
- 498
-
Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramineMarek, G. J. et al. | 2008
- 508
-
Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbensJerlhag, E. / Egecioglu, E. / Dickson, S. L. / Svensson, L. / Engel, J. r. et al. | 2008
- 519
-
Cannabinoid and opioid modulation of social play behavior in adolescent rats: Differential behavioral mechanismsTrezza, V. / Vanderschuren, L. J. et al. | 2008
- 531
-
Repeated treatment with haloperidol, but not olanzapine, alters synaptic NMDA receptor composition in rat striatumGardoni, F. / Frasca, A. / Zianni, E. / Riva, M. A. / Di Luca, M. / Fumagalli, F. et al. | 2008
- 535
-
ECNP consensus meeting. Bipolar depression. Nice, March 2007Goodwin, G. M. / Anderson, I. / Arango, C. / Bowden, C. L. / Henry, C. / Mitchell, P. B. / Nolen, W. A. / Vieta, E. / Wittchen, H. U. et al. | 2008
- 551
-
Cocaine self-administration produces a persistent increase in dopamine D2High receptorsBriand, L. A. / Flagel, S. B. / Seeman, P. / Robinson, T. E. et al. | 2008
- 557
-
In vivo occipital–frontal temperature-gradient in schizophrenia patients and its possible association with psychopathology: A magnetic resonance spectroscopy studyShiloh, R. / Kushnir, T. / Gilat, Y. / Gross-Isseroff, R. / Hermesh, H. / Munitz, H. / Stryjer, R. / Weizman, A. / Manor, D. et al. | 2008
- 565
-
Sodium butyrate, an epigenetic interventional strategy, attenuates a stress-induced alteration of MK-801's pharmacologic actionDeutsch, S. I. / Rosse, R. B. / Long, K. D. / Gaskins, B. L. / Burket, J. A. / Mastropaolo, J. et al. | 2008
- 569
-
Effects of acute oral Δ9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteersRoser, P. / Juckel, G. / Rentzsch, J. / Nadulski, T. / Gallinat, J. r. / Stadelmann, A. M. et al. | 2008
- 578
-
Involvement of septal Cdk5 in the emergence of excessive anxiety induced by stressBignante, E. A. / Rodriguez Manzanares, P. A. / Mlewski, E. C. / Bertotto, M. a. / Bussolino, D. F. / Paglini, G. / Molina, V. A. et al. | 2008
- 589
-
Switching schizophrenia patients from typical neuroleptics to olanzapine: Effects on BOLD response during attention and working memorySchlagenhauf, F. / Wüstenberg, T. / Schmack, K. / Dinges, M. / Wrase, J. / Koslowski, M. / Kienast, T. / Bauer, M. / Gallinat, J. r. / Juckel, G. et al. | 2008
- 600
-
Region-specific involvement of AMPA/Kainate receptors in Fos protein expression induced by cocaine-conditioned cuesZavala, A. R. / Browning, J. R. / Dickey, E. D. / Biswas, S. / Neisewander, J. L. et al. | 2008
- 612
-
Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokersSneider, J. T. / Pope, H. G. / Silveri, M. M. / Simpson, N. S. / Gruber, S. A. / Yurgelun-Todd, D. A. et al. | 2008
- 620
-
Guanosine and its modulatory effects on the glutamatergic systemSchmidt, A. P. / Tort, A. B. / Lara, D. R. / Souza, D. O. et al. | 2008
- 623
-
A regulatory Apologia — A review of placebo-controlled studies in regulatory submissions of new-generation antidepressantsMelander, H. / Salmonson, T. / Abadie, E. / van Zwieten-Boot, B. et al. | 2008
- 628
-
Certain or uncertain cocaine expectations influence accumbens dopamine responses to `self-administered cocaine and non-rewarded operant behaviorD'Souza, M. S. / Duvauchelle, C. L. et al. | 2008
- 639
-
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorderMischoulon, D. / Best-Popescu, C. / Laposata, M. / Merens, W. / Murakami, J. L. / Wu, S. L. / Papakostas, G. I. / Dording, C. M. / Sonawalla, S. B. / Nierenberg, A. A. et al. | 2008
- 646
-
Strategies of treatment with olanzapine in schizophrenic patients during stable phase: Results of a pilot studyRouillon, F. d. / Chartier, F. / Gasquet, I. et al. | 2008
- 653
-
Brief post-stressor treatment with pregabalin in an animal model for PTSD: Short-term anxiolytic effects without long-term anxiogenic effectZohar, J. / Matar, M. A. / Ifergane, G. / Kaplan, Z. / Cohen, H. et al. | 2008
- 667
-
Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemiaPoyraz, B. / Aksoy, C. / Balcıoğlu, b. et al. | 2008
- 673
-
Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: A double-blind placebo-controlled trialDavidson, J. R. / Wittchen, H. U. / Llorca, P. M. / Erickson, J. / Detke, M. / Ball, S. G. / Russell, J. M. et al. | 2008
- 682
-
The role of D1–D2 receptor hetero-dimerization in the mechanism of action of clozapineFaron-Górecka, A. / Górecki, A. / Kuśmider, M. / Wasylewski, Z. / Dziedzicka-Wasylewska, M. et al. | 2008
- 692
-
Serotonergic responses in depressed patients with or without a history of alcohol use disorders and healthy controlsSher, L. / Stanley, B. H. / Cooper, T. B. / Malone, K. M. / Mann, J. J. / Oquendo, M. A. et al. | 2008
- 701
-
The circadian basis of mood disorders: Recent developments and treatment implicationsMonteleone, P. / Maj, M. et al. | 2008
- 712
-
Dopamine and serotonin levels following prenatal viral infection in mouse—Implications for psychiatric disorders such as schizophrenia and autismWinter, C. / Reutiman, T. J. / Folsom, T. D. / Sohr, R. / Wolf, R. J. / Juckel, G. / Fatemi, S. H. et al. | 2008
- 717
-
Illness duration and total brain gray matter in bipolar disorder: Evidence for neurodegeneration?Frey, B. N. / Zunta-Soares, G. B. / Caetano, S. C. / Nicoletti, M. A. / Hatch, J. P. / Brambilla, P. / Mallinger, A. G. / Soares, J. C. et al. | 2008
- 723
-
Abuse liability of intra-nasal midazolam in inhaled-cocaine abusersBraun, I. M. / Tavares, H. / de Nucci, G. / Bernik, M. et al. | 2008
- 729
-
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: A comparison to other agentsBrocco, M. / Dekeyne, A. / Mannoury la Cour, C. / Touzard, M. / Girardon, S. / Veiga, S. / de Nanteuil, G. / deJong, T. R. / Olivier, B. / Millan, M. J. et al. | 2008
- 751
-
Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major DepressionDomschke, K. / Dannlowski, U. / Ohrmann, P. / Lawford, B. / Bauer, J. / Kugel, H. / Heindel, W. / Young, R. / Morris, P. / Arolt, V. et al. | 2008
- 760
-
Experimentally induced various inflammatory models and seizure: Understanding the role of cytokine in ratRao, R. S. / Medhi, B. / Saikia, U. N. / Arora, S. K. / Toor, J. S. / Khanduja, K. L. / Pandhi, P. et al. | 2008
- 768
-
Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophreniaMössner, R. / Schuhmacher, A. / Schulze-Rauschenbach, S. / Kühn, K. U. / Rujescu, D. / Rietschel, M. / Zobel, A. / Franke, P. / Wölwer, W. / Gaebel, W. et al. | 2008
- 773
-
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacologyPaz, R. D. / Tardito, S. / Atzori, M. / Tseng, K. Y. et al. | 2008
- 787
-
Cognitive impairment in bipolar disorder: Neurodevelopment or neurodegeneration? An ECNP expert meeting reportGoodwin, G. M. / Martinez-Aran, A. / Glahn, D. C. / Vieta, E. et al. | 2008
- 794
-
Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorderBisaga, A. / Danysz, W. / Foltin, R. W. et al. | 2008
- 803
-
Continuation and long-term maintenance treatment with Hypericum extract WS® 5570 after recovery from an acute episode of moderate depression — A double-blind, randomized, placebo controlled long-term trialKasper, S. / Volz, H. P. / Möller, H. J. / Dienel, A. / Kieser, M. et al. | 2008
- 814
-
Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonistPerera, P. Y. / Lichy, J. H. / Mastropaolo, J. / Rosse, R. B. / Deutsch, S. I. et al. | 2008
- 820
-
Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean populationKim, Y. R. / Kim, J. H. / Kim, S. J. / Lee, D. / Min, S. K. et al. | 2008
- 826
-
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effectsEllgren, M. / Artmann, A. / Tkalych, O. / Gupta, A. / Hansen, H. S. / Hansen, S. H. / Devi, L. A. / Hurd, Y. L. et al. | 2008
- 835
-
The recognition of facial emotion expressions in Parkinson's diseaseAssogna, F. / Pontieri, F. E. / Caltagirone, C. / Spalletta, G. et al. | 2008
- 849
-
Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned ratsBitencourt, R. M. / Pamplona, F. c. / Takahashi, R. N. et al. | 2008
- 860
-
Differential modulation of cytokine production in major depressive disorder by cortisol and dexamethasoneHeiser, P. / Lanquillon, S. / Krieg, J. C. / Vedder, H. et al. | 2008
- 871
-
Attenuation of methamphetamine-induced effects through the antagonism of sigma (σ) receptors: Evidence from in vivo and in vitro studiesMatsumoto, R. R. / Shaikh, J. / Wilson, L. L. / Vedam, S. / Coop, A. et al. | 2008
- 882
-
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusersAngelucci, F. / Ricci, V. / Spalletta, G. / Pomponi, M. / Tonioni, F. / Caltagirone, C. / Bria, P. et al. | 2008
- 888
-
Distinct contributions of dopamine receptors in the nucleus accumbens core or shell to established cocaine reinforcement under a second-order scheduleDi Ciano, P. et al. | 2008
- 897
-
Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazoleKwon, J. S. / Kim, E. / Kang, D. H. / Choi, J. S. / Yu, K. S. / Jang, I. J. / Shin, S. G. / APLUS, s. g. et al. | 2008
- 908
-
The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effectsBreuer, M. E. / Chan, J. S. / Oosting, R. S. / Groenink, L. / Korte, S. M. / Campbell, U. / Schreiber, R. / Hanania, T. / Snoeren, E. M. / Waldinger, M. et al. | 2008
- 917
-
Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorderHernández, M. a. / Mendieta, D. / Martínez-Fong, D. / Loría, F. / Moreno, J. / Estrada, I. / Bojalil, R. / Pavón, L. et al. | 2008
- I
-
ECNP announcement - Call for applications - Editor-in-Chief| 2008
- s1
-
S.1.01 Neuropeptidergic mechanisms and mental diseaseHokfelt, T. / Ogren, S. O. et al. | 2008
- s2
-
P.1.01 The effect of influenza A/WSN/33 virus infections on the kynurenine pathwayAsp, L. / Holtze, M. / Schwieler, L. / Engberg, G. / Karlsson, H. et al. | 2008
- s3
-
P.1.02 Effects of stress and antidepressants on glutamate release and presynaptic molecular mechanismsBarbiero, V. / Zappettini, S. / Mallei, A. / Milanese, M. / Musazzi, L. / Giambelli, R. / Racagni, G. / Bonanno, G. / Popoli, M. et al. | 2008
- s4
-
P.1.03 Molecular effects of subchronic and chronic treatment with escitalopram in the rat central nervous systemBenatti, C. / Alboni, S. / Capone, G. / Corsini, D. / Caggia, F. / Blom, J. M. / Tascedda, F. / Brunello, N. et al. | 2008
- s5
-
P.1.05 Involvement of DARPP-32, FosB, and dynorphin in voluntary wheel runningBorgkvist, A. / Nestler, E. J. / Greengard, P. / Fisone, G. / Brene, S. et al. | 2008
- s6
-
P.1.06 Impaired mitochondrial respiration due to dopamine inhibition of complex I activity: implication to schizophreniaLavie, H. B. / Klein, E. / Ben-shachar, D. et al. | 2008
- s7
-
P.1.07 Regulation of brain-derived neurotrophic factor expression by cocaine in rat brain and its modulation by stressCaffino, L. / Racagni, G. / Riva, M. A. / Fumagalli, F. et al. | 2008
- s9
-
P.1.10 The depression case control study in the whole genome association era: results and implications for the futureCohen, S. / Pirlo, K. / Schosser, A. / Gaysina, D. / Craddock, N. / Korszun, A. / Owen, M. / Craig, I. / Farmer, A. / McGuffin, P. et al. | 2008
- s10
-
P.1.11 Neurobiology of improved stress-coping in voluntarily exercising ratsCollins, A. / Droste, S. K. / Linthorst, A. C. / Reul, J. M. et al. | 2008
- s11
-
P.1.12 The neuroprotective effects of the group III metabotropic glutamate receptor agonist ACPT-1 in vitro and in vivoDomin, H. / Kajta, M. / Zieba, B. / Smialowska, M. et al. | 2008
- s13
-
P.1.15 Association of dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS)Gaysina, D. / Cohen, S. / Chow, P. C. / Martucci, L. / Tozzi, F. / Perry, J. / Muglia, P. / Craig, I. W. / McGuffin, P. / Farmer, A. et al. | 2008
- s14
-
P.1.16 A putative mechanism for interleukin-1- associated nociception via astrocytic glutamate transporters modulationZiv, N. / Shavit, Y. / Tal, M. et al. | 2008
- s15
-
P.1.17 Topographical and temporal distribution of Homer1a expression is correlated to antipsychotics dopaminergic profileIasevoli, F. / Ambesi-Impiombato, A. / Fiore, G. / Panariello, F. / Muscettola, G. / de Bartolomeis, A. et al. | 2008
- s17
-
P.1.20 Mechanisms of the antidepressant action of triiodothyronine: functional, behavioral and gene expression studiesLifschytz, T. / Shalom, G. / Goltser-Dubner, T. / Segman, R. H. / Lerer, B. / Newman, M. et al. | 2008
- s18
-
P.1.21 Aberrant hippocampal expression of immune signalling-related genes in the rodent models of schizophreniaLukasz, B. / Murphy, K. et al. | 2008
- s19
-
P.1.22 Synaptoproteomic analysis of a rat model of depression with gene-environment interactionMallei, A. / Giambelli, R. / Barbiero, V. S. / Musazzi, L. / El Khoury, A. / Gruber, S. H. / Mathe, A. A. / Racagni, G. / Popoli, M. et al. | 2008
- s21
-
P.1.25 Striatal synaptic and cortical nuclear orphan G protein-coupled receptor GPR88, a promising target for psychiatric and movement disordersMassart, R. / Guilloux, J. P. / Mignon, V. / Lauressergues, E. / Cussac, D. / Sokoloff, P. / Diaz, J. et al. | 2008
- s22
-
P.1.26 Morphological analyses of neurons in serotonin transporter (5-Htt) knockout miceNietzer, S. et al. | 2008
- s23
-
P.1.27 The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor and FK506 binding protein 51 (FKBP-51) concentration in animal model of depressionOtczyk, M. / Budziszewska, B. / Jaworska-Feil, L. / Basta-Kaim, A. / Kubera, M. / Regulska, M. / Leskiewicz, M. / Lason, W. et al. | 2008
- s25
-
P.1.30 Inflammation down-regulates b2-adrenoceptor expression on primary glia: reversal by the glucocorticoid dexamethasoneRyan, K. M. / McNamee, E. N. / Connor, T. J. et al. | 2008
- s26
-
P.1.31 Gender-related differences in synaptic transmission and plasticity in the mouse striatum and nucleus accumbensSchotanus, S. M. / Chergui, K. et al. | 2008
- s27
-
P.1.32 Imidazoline2 (I2) binding site ligands increase Fos-like immunoreactivity in the naive and restraint-stressed rat brainSmith, K. / Roche, M. / Jessop, D. S. / Finn, D. P. et al. | 2008
- s28
-
P.1.34 Progesterone and estradiol plasma levels modulate serotonin-1A binding in the human brainSpindelegger, C. / Mitterhauser, M. / Stein, P. / Mien, L. K. / Moser, U. / Fink, M. / Wadsak, W. / Kletter, K. / Kasper, S. / Lanzenberger, R. et al. | 2008
- s29
-
P.1.35 Hippocampal expression of BDNF is involved in the behavioral effects of the b3 adrenoceptor agonist, SR58611ATamburella, A. / Micale, V. / Leggio, G. M. / Drago, F. et al. | 2008
- s30
-
P.1.36 Caffeine exacerbates MDMA "Ecstasy"-induced hyperthermia: a role for dopamine D1 receptorsVanattou-Saifoudine, N. / McNamara, R. / Harkin, A. et al. | 2008
- s31
-
P.1.37 Proline affects brain function in 22q11DS children with the low-activity COMT158 alleleVorstman, J. A. / Turetsky, B. I. / Dorland, L. / Sprong, M. / Emanuel, B. S. / Kahn, R. S. / de Sain, M. / Engeland, H. / Kemner, C. / Beemer, F. A. et al. | 2008
- s32
-
P.1.38 Splice variants of hippocampal NR1 subunit of NMDA receptor in schizophreniaVrajova, M. / Lochman, J. / Pekova, S. / Stastny, F. et al. | 2008
- s35
-
S.2.01 Psychopharmacological models focusing on stimulus bound behaviourMarkou, A. et al. | 2008
- s36
-
S.2.02 Novel approaches in behavioural genomicsKas, M. J. et al. | 2008
- s37
-
P.2.01 The effect of fatty acid amide hydrolase inhibitors in cocaine or food self administrationAdamczyk, P. / Wydra, K. / Nowak, E. / McCreary, A. / Filip, M. / Przegalinski, E. et al. | 2008
- s38
-
P.2.02 Differential sensitivity to dopaminergic manipulations following ovariectomy: an animal model of menopausal psychosisArad, M. / Weiner, I. et al. | 2008
- s40
-
P.2.05 Behavioural responses to morphine in mutants with progressive ablation of D1 receptor-expressing cellsBabovic, D. / Gantois, I. / Jiang, L. / Waddington, J. / Drago, J. et al. | 2008
- s41
-
P.2.06 MDMA modifies active avoidance learning and recall in miceTrigo-Diaz, J. / Cabrero-Castel, A. / Berrendero, F. / Maldonado, R. / Robledo, P. et al. | 2008
- s42
-
P.2.07 Muscarinic transmission in the entorhinal cortex mediates inattention to irrelevant stimuli: relevance to schizophreniaBarak, S. / Weiner, I. et al. | 2008
- s43
-
P.2.08 Attention in adolescents recovered from major depressionWilkinson, P. / Goodyer, I. et al. | 2008
- s44
-
P.2.10 Aberrant cytokine response to stress in BALB/c mice after lipopolysaccharide (LPS) challenge: relevance of tryptophan hydroxylase 2Browne, C. A. / OBrien, F. / Connor, T. J. / Cryan, J. F. et al. | 2008
- s45
-
P.2.11 Gene function in social and non-social memoryBruining, H. / van Engeland, H. / Oppelaar, H. / Petri, E. / Kas, M. J. et al. | 2008
- s46
-
P.2.12 A role for the opioid system in endocannabinoid-mediated fearconditioned analgesia in ratsButler, R. K. / Rea, K. / Lang, Y. / Finn, D. P. et al. | 2008
- s47
-
P.2.13 Translational research into sexual disorders: pharmacology and behaviorChan, J. / Oosting, R. S. / Kooijman, E. / van Hasselt, F. N. / Snoeren, E. M. / Waldinger, M. D. / Olivier, B. et al. | 2008
- s48
-
P.2.15 Behavioural changes in NPY-Y2 and 5HT-1a receptor deficient mice in an automated home cage task for avoidance behaviourde Mooij-van Malsen, J. G. / Olivier, B. / Herzhog, H. / Kas, M. J. et al. | 2008
- s49
-
P.2.16 Environmental stimulation reduces the rewarding effects of heroinEl Rawas, R. / Thiriet, N. / Jaber, M. / Solinas, M. et al. | 2008
- s50
-
P.2.17 Estradiol decreases ventral tegmental area self-stimulation threshold and increases cocaine rewarding properties in ratsGalankin, T. / Belozertseva, I. V. / Shekunova, E. V. / Zvartau, E. E. et al. | 2008
- s51
-
P.2.18 Effects of serotonin1B (5-HT1B) receptor ligands in cocaine priming, discrete cue or food-induced relapses in ratsGolda, A. / Filip, M. / Wydra, K. / Przegalinski, E. et al. | 2008
- s52
-
P.2.20 Could nicotine potentiate the beneficial effects of levodopa in the 6-OHDA rat model? A behavioural studyGuilloux, J. P. / Massart, R. / Mignon, V. / Diaz, J. / Arrang, J. M. et al. | 2008
- s53
-
P.2.21 Exposure to an open-field induces c-Fos in a distributed anxiety-related system projecting to the basolateral amygdalaHale, M. / Hay-Schmidt, A. / Mikkelsen, J. / Poulsen, B. / Shekhar, A. / Lowry, C. et al. | 2008
- s54
-
P.2.22 Impact of behavioural sensitization to methamphetamine on i.v. selfadminitration of the drug in male and female ratsKucerova, J. / Vrskova, D. / Sulcova, A. et al. | 2008
- s55
-
P.2.23 Neuropsychopharmacological specificity in drug addiction: no cross-escalation between cocaine and heroin useLenoir, M. / Ahmed, S. H. et al. | 2008
- s57
-
P.2.26 Significance of a genetically de.ned GABAA-receptor de.cit on breathing behaviour: relevance to respiratory panicMasneuf, S. / Crestani, F. et al. | 2008
- s58
-
P.2.27 Role of neurosteroids in the modulation of neuropeptide Y Y1 receptor neurotransmission during ethanol and ghb withdrawalMele, P. / Nai, A. / Serra, M. / Pisu, M. G. / Eva, C. / Biggio, G. et al. | 2008
- s60
-
P.2.30 Triple dissociation of serotonergic in.uence on motivational behaviour under positive, negative and neutral moodRobinson, O. J. / Sahakian, B. J. et al. | 2008
- s64
-
P.3.03 Seven days of citalopram reduces sensitivity to negative appraisal in a probabilistic learning taskBrowning, M. / Rudebeck, S. / Murphy, S. E. / Cowen, P. J. / Harmer, C. J. et al. | 2008
- s65
-
P.3.04 Neurocognitive functioning in patients with different type of abuseBushara, N. / Fishbein, D. H. / Flannery, B. A. / Langevin, D. J. / Bobashev, G. / Zvartau, E. E. / Verbitskaya, E. V. / Tsoy, M. V. / Krupitsky, E. M. / Egorova, V. U. et al. | 2008
- s66
-
P.3.05 Current and former ecstasy users report different sleep to matched controls: a web based questionnaire studyCarhart-Harris, R. / Nutt, D. J. / Munafo, M. / Wilson, S. J. et al. | 2008
- s67
-
P.3.06 Tryptophan degradation in psychosis: simultaneous measurement of tryptophan and kynurenine pathway metabolites by HPLCClarke, G. / Barry, S. / Scully, P. / Cryan, J. F. / Dinan, T. G. et al. | 2008
- s68
-
P.3.07 Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysisCruz, N. / Goikolea, J. M. / Sanchez-Moreno, J. / Vieta, E. et al. | 2008
- s69
-
P.3.09 The predictive value of neurocognitive decision-making for heavy alcohol use in a longitudinal, prospective studyGoudriaan, A. / Grekin, E. R. / Sher, K. J. et al. | 2008
- s70
-
P.3.10 Glutamate and interleukin receptor genes are associated with antidepressant treatment emergent suicidal ideationMenke, A. / Lucae, S. / Kloiber, S. / Horstmann, S. / Uhr, M. / Putz, B. / Ripke, S. / Muller-Myhsok, B. / Binder, E. / Holsboer, F. et al. | 2008
- s71
-
P.3.11 Hypothalamic serotonin-1A receptor binding correlates with plasma levels of dehydroepiandrosterone and cortisolMoser, U. / Stein, P. / Spindelegger, C. J. / Wadsak, W. / Mitterhauser, M. / Holik, A. / Bieglmayer, C. / Lanzenberger, R. / Kletter, K. / Kasper, S. et al. | 2008
- s72
-
P.3.12 Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processingMurphy, S. E. / Rudebeck, S. / Browning, M. / Cowen, P. J. / Harmer, C. J. et al. | 2008
- s73
-
P.3.14 Specific antipsychotic medications-a treatment for aggressive behaviour in schizophrenia?Patel, K. / Khalid, F. / Cree, A. / Sainz-Fuertes, R. / Shortt, M. / Mak, T. / Alderton, J. / Hodgins, S. et al. | 2008
- s74
-
P.3.15 Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patientsPawelczyk, A. / Pawelczyk, T. / Rabe-Jablonska, J. et al. | 2008
- s75
-
P.3.16 Characterisation of response to antidepressants in a pharmacogenetic trialUher, R. / Maier, W. / Rietschel, M. / Hauser, J. / Mors, O. / Marusic, A. / Henigsberg, N. / Perez, J. / Mendlewicz, J. / McGuffin, P. et al. | 2008
- s76
-
P.3.17 Do patients benefit from practice? An fMRI study in first episode schizophreniavan Veelen, N. / Vink, M. / Ramsey, N. F. / Kahn, R. S. et al. | 2008
- s77
-
P.3.18 Cognitive test scores are lower in adolescent cigarette smokers compared to non-smokers: a population-based studyWerbeloff, N. / Lubin, G. / Zarka, S. / Shmushkevitch, M. / Kravitz, E. / Davidson, M. / Weiser, M. et al. | 2008
- s78
-
P.3.19 Effects of acute alcohol consumption on the processing of perceptual cues of emotional expressionAttwood, A. S. / Benton, C. P. / Penton-Voak, I. S. / Munafo, M. R. et al. | 2008
- s80
-
P.3.22 Serotonin1A receptor distribution may predict neural reactivity as shown by multimodal neuroimaging with fMRI and PETFink, M. / Lanzenberger, R. / Mitterhauser, M. / Windischberger, C. / Stein, P. / Spindelegger, C. / Wadsak, W. / Moser, U. / Kletter, K. / Kasper, S. et al. | 2008
- s81
-
P.3.23 Molecular imaging of early visual cortex by combining pet and fMRIGerstl, F. / Windischberger, C. / Moser, E. / Kasper, S. / Lanzenberger, R. et al. | 2008
- s82
-
P.3.24 Lower 5-HT1A receptor binding in patients with borderline personality disorder: a PET study using [11C]WAY100635Jovanovic, H. / Andersson, E. E. / Karlsson, P. / Halldin, C. / Nordstom, A. L. / Asberg, M. / Farde, L. et al. | 2008
- s85
-
P.4.01 Butyrylcholinestherase K variant and apolipoprotein E (APOE) state in subcortical vascular dementia and Alzheimers diseaseAlmos, P. / Juhasz, A. / Boda, K. / Janka, Z. / Kalman, J. et al. | 2008
- s86
-
P.4.02 Transforming growth factor-b1 (TGF-b1) signaling as a new pharmacological target against Ab-induced neurodegenerationCaraci, F. / Battaglia, G. / Busceti, C. / Biagioni, F. / Leggio, G. M. / Bosco, P. / Drago, F. / Nicoletti, F. / Sortino, M. A. / Copani, A. et al. | 2008
- s88
-
P.4.05 The attenuating effect of memantine on doxorubicin-induced apoptosis of primary neurons and neuroblastoma SH-SY5Y cellsJantas, D. / Lason, W. et al. | 2008
- s89
-
P.4.06 Regional sensitivity or resistance to neuroinflammation: in vivo and in vitro studiesZaltsman, S. L. / Fishbein, I. / Greeneberger, V. / Shohami, E. / Biegon, A. et al. | 2008
- s90
-
P.4.07 Peroxisome proliferator-activated receptors (PPARs): new target for attention and memory functionMazzola, C. / Medalie, J. / Panlilio, L. V. / Hahn, B. / Goldberg, S. R. / Yasar, S. / Drago, F. et al. | 2008
- s92
-
P.4.10 Nicotinic acetylcholine receptor (nAChR) desensitization and its relevance to physiological and behavioral functionsShacar, M. / Heldman, E. / Cohen, H. et al. | 2008
- s93
-
P.4.11 The effect of rivastigmine on learning and memory processes after bilateral nucleus basalis of Meynert lesions in ratsMellios, G. / Kallaras, K. / Pazaiti, A. / Papazisis, G. / Koutsonikolas, D. / Guiba-Tziampiri, O. et al. | 2008
- s95
-
Author Index| 2008
- s99
-
Keyword Index| 2008
- S102
-
Overcoming hurdles to achieving good physical health in patients treated with atypical antipsychoticsFagiolini, A. et al. | 2008
- S109
-
Prolactin awareness: An essential consideration for physical health in schizophreniaMontejo, A. L. et al. | 2008
- S116
-
Psychosocial and economic issues related to physical health in psychiatric illnessThomas, P. et al. | 2008
- S122
-
Management of physical health in schizophrenia: A stepping stone to treatment successMillar, H. et al. | 2008
- S129
-
Schizophrenia: From developmental deviance to dopamine dysregulationMurray, R. M. / Lappin, J. / Di Forti, M. et al. | 2008
- S135
-
Limitations of current therapies: Why do patients switch therapies?Falkai, P. et al. | 2008
- S140
-
Monitoring patients to improve physical health and treatment outcomeLlorca, P. M. et al. | 2008
- S146
-
Do we need another atypical antipsychotic?Kasper, S. et al. | 2008
- S156
-
S.02.01 Molecular genetic findings in suicide: what lies beyond the serotonergic system?Reif, A. / Jacob, C. P. / Rujescu, D. / Strobel, A. / Herterich, S. / Giegling, I. / Hartmann, A. / Lesch, K. P. et al. | 2008
- S157
-
S.02.04 Suicide prevention in bipolar disorder: a reality?Isometsa, E. T. et al. | 2008
- S158
-
S.03.02 Promotion of sleep through an orally available hypocretin/orexin antagonist in rats, dogs and humansJenck, F. / Brisbare-Roch, C. / Aissaoui, H. / Koberstein, R. et al. | 2008
- S160
-
S.04.02 Imidazoline2 (I2) binding site ligands increase Fos-like immunoreactivity in the naive and restraint-stressed rat brainSmith, K. L. / Roche, M. / Jessop, D. S. / Finn, D. P. et al. | 2008
- S162
-
S.04.07 Could nicotine potentiate the beneficial effects of levodopa in the 6-OHDA rat model? A behavioural studyGuilloux, J. P. / Massart, R. / Samaha, A. N. / Mignon, V. / Arrang, J. M. / Diaz, J. et al. | 2008
- S163
-
S.05.02 Bipolar Disorder: neurodevelopmental or neurodegenerativeMartinez-Aran, A. et al. | 2008
- S164
-
S.05.05 Future prospects on the biological and treatment correlates of cognitive deficits in affective disordersMalhi, G. S. / Lagopoulos, J. et al. | 2008
- S165
-
S.06.02 Genetics of early onset in OCDWalitza, S. / Renner, J. / Lange, K. W. / Lesch, K. P. / Warnke, A. et al. | 2008
- S166
-
S.06.04 Neuropsychological endophenotypes in families with OCDFineberg, N. / Chamberlain, S. R. / Menzies, L. A. / Craig, K. / Morein-Zamir, S. / Sahakian, B. J. / Robbins, T. W. / Bullmore, E. T. et al. | 2008
- S168
-
S.07.05 Proline affects brain function in 22q11DS children with the low-activity COMT158 alleleVorstman, J. A. / Turetsky, B. I. / Sprong, M. / de Sain, M. G. / Rappaport, E. F. / Beemer, F. A. / Emanuel, B. S. / Kahn, R. S. / van Engeland, H. / Kemner, C. et al. | 2008
- S169
-
S.07.07 Seven days of citalopram reduces sensitivity to negative appraisal in a probabilistic learning taskBrowning, M. / Rudebeck, S. / Murphy, S. E. / Cowen, P. J. / Harmer, C. J. et al. | 2008
- S170
-
S.08.02 The therapeutic potential of drugs that target the endogenous cannabinoid systemPertwee, R. et al. | 2008
- S173
-
S.11.01 The prevalence, course and burden of anxiety disordersBeesdo, K. / Wittchen, H. U. et al. | 2008
- S174
-
S.11.04 The use of inbred strains for the development of animal models of anxietyLandgraf, R. et al. | 2008
- S176
-
S.15.03 Early experiences affect brain and behaviour: a comparison of rat and human mothersFleming, A. S. / Afonso, V. / Lovic, V. / Gonzalez, A. / Chatterjee, M. / Chatterjee, D. et al. | 2008
- S177
-
S.15.05 The risk:benefit ratio of using antidepressants during pregnancySteiner, M. et al. | 2008
- S178
-
S.16.03 Stem cells and treatment of brain and spinal cord injurySykova, E. et al. | 2008
- S180
-
S.17.04 Brain activation by CRF: relationship to stress-related disordersSteckler, T. / Warnock, G. / Schmidt, M. et al. | 2008
- S182
-
S.18.04 Early-onset psychotic patients growing up: clinical, imaging and neuropsychological findingsMoreno, C. / Parellada, M. / Moreno, D. / Reig, S. / Mayoral, M. / Fraguas, D. / Desco, M. / Arango, C. et al. | 2008
- S183
-
S.20.01 Studies on lithium by the use of GSK-3b knockout miceBelmaker, R. et al. | 2008
- S184
-
S.20.04 Lithium responsive behavioural models: a tool for understanding atypical antipsychotic action in bipolar depression and maniaGould, T. / Kovacsics, C. / ODonnell, K. / Dow, E. / Chen, G. / Manji, H. et al. | 2008
- S185
-
S.21.01 Cognition-enhancing interventions as early treatment in schizophreniaBuchanan, R. W. et al. | 2008
- S186
-
S.21.05 The role of NMDAR neurotransmission modulators in the early treatment of schizophreniaHeresco-Levy, U. et al. | 2008
- S187
-
S.22.03 Brain imaging and PTSDVermetten, E. / Geuze, E. / Westenberg, H. G. et al. | 2008
- S189
-
S.23.03 CO2 models in anxiety disordersPerna, G. / Caldirola, D. / Galimberti, E. / Menotti, R. / Bellodi, L. et al. | 2008
- S190
-
S.24.01 Neurosteroids: endogenous modulators of GABA-A receptorLambert, J. / Gunn, B. / Brown, A. / Mitchell, E. / Simmons, R. / Herd, M. B. / Belelli, D. et al. | 2008
- S192
-
S.25.03 Use of antidepressants in long treatment of bipolar depressionGoikolea, J. et al. | 2008
- S194
-
S.26.03 Endogenous opioids and impulsive responding in alcoholics and healthy controlsBoettiger, C. A. et al. | 2008
- S196
-
S.28.02 Brain localization of cytochrome P450Loriot, M. A. / Dutheil, F. / Flinois, J. P. / Duyckaerts, C. / Beaune, P. H. et al. | 2008
- S199
-
E.01.03 Antipsychotics in anxiety disordersAllgulander, C. et al. | 2008
- S200
-
E.04.01 Phytotherapy in psychiatry: myths and factsDelini-Stula, A. / Holsboer-Trachsler, E. et al. | 2008
- S201
-
E.05.03 Psycho-educationMotlova, L. / Spaniel, F. et al. | 2008
- S203
-
P.1.a.002 Glial cell-derived neurotrophic family (GFR) alpha 1 receptor polymorphisms and weight change during clozapine treatmentSouza, R. / Romano-Silva, M. A. / Lieberman, J. A. / Meltzer, H. Y. / Culotti, J. / Kennedy, J. L. / Wong, A. H. et al. | 2008
- S204
-
P.1.a.004 Chromosomal aberrations in an African schizophrenia populationKoen, L. / Niehaus, D. J. / De Jong, G. / Emsley, R. A. et al. | 2008
- S205
-
P.1.a.006 Serotonin transporter: an example of gene influence on human behaviourCalati, R. / De Ronchi, D. / Serretti, A. et al. | 2008
- S207
-
P.1.a.009 CYP2D6 polymorphism in patients with Alzheimers disease in treatment with cholinesterase inhibitorsFontana, M. / Squitti, R. / Bonvicini, C. / Benussi, L. / Bocchio Chiavetto, L. / Ventriglia, M. et al. | 2008
- S208
-
P.1.a.011 Effect of angiotension-converting enzyme gene i/d polymorphism on training- and detraining-induced changes in adiposityYi, J. S. / Lee, H. S. et al. | 2008
- S209
-
P.1.a.013 The association of BDNF gene val66met polymorphism with the serum BDNF levels in drug-free depressed patientsOzan, E. / Gonul, A. S. / Okur, H. / Akarsu, N. / Eker, C. / Eker, O. D. / Yulug, B. / Aydin, N. / Kirpinar, I. et al. | 2008
- S210
-
P.1.a.014 Dopamine D2 receptor gene polymorphisms and tardive dyskinesia in schizophrenia patientsLee, H. J. / Kang, S. G. / Cho, C. H. / Choi, J. E. / Kim, L. et al. | 2008
- S211
-
P.1.a.016 GABAergic control of stress-responsive epigenetic and gene expression mechanisms in the dentate gyrusPapadopoulos, A. / Chandramohan, Y. / Collins, A. / Droste, S. K. / Nutt, D. J. / Reul, J. M. et al. | 2008
- S212
-
P.1.a.018 The influence of 5-HTT, DRD2, DAT1 and NET genes on personality traits is modified by gene - environment interactionKazantseva, A. / Gaysina, D. / Khusnutdinova, E. et al. | 2008
- S213
-
P.1.a.019 AKT1 gene single nucleotide polymorphism in Korean patients of schizophrenia and bipolar disorderKim, E. J. / Lee, K. Y. et al. | 2008
- S214
-
P.1.a.021 Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatientsHorstmann, S. / Lucae, S. / Menke, A. / Ising, M. / Muller-Myhsok, B. / Holsboer, F. / Binder, E. et al. | 2008
- S215
-
P.1.a.023 No association between dopamine receptor D4 521 c/t gene polymorphism and bipolar disorder and it subtypesRajewska-Rager, A. / Leszczynska-Rodziewicz, A. / Dmitrzak-Weglarz, M. / Skibinska, M. / Rybakowski, J. K. / Hauser, J. et al. | 2008
- S216
-
P.1.a.024 The s allele of the 5-HTTLPR: a possible genetic correlate of traits associated with neuroticismGonda, X. / Fountoulakis, K. N. / Lazary, J. / Rihmer, Z. / Akiskal, H. S. / Bagdy, G. et al. | 2008
- S217
-
P.1.b.002 Detrended fluctuation analysis of heart rate variability in obstructive sleep apneaShin, C. J. / Park, D. H. et al. | 2008
- S218
-
P.1.b.004 Activation of thalamo-cortical circuits by phencyclidine, reversal by clozapineSantana, N. / Celada, P. / Mengod, G. / Artigas, F. et al. | 2008
- S219
-
P.1.b.005 Auditory and visual event-related potential P300 as a "trait" and a "state" markers in patients with schizophreniaJeon, Y. / Yi, J. / Park, E. et al. | 2008
- S220
-
P.1.c.001 An ethopharmacological assessment of the effects of (R, S)-2-chloro-5-hydroxyphenylglycine (CHPG) on agonistic interactions in male miceHuertas, P. / Martin-Lopez, M. / Buron, E. / Navarro, J. F. et al. | 2008
- S222
-
P.1.c.004 Acute paroxetine or alprazolam attenuate defensive responses of hamsters confronted with venomous coral snakePaschoalin-Maurin, T. / Coimbra, N. C. et al. | 2008
- S223
-
P.1.c.006 Involvement of A2A receptors in anxiolytic, locomotor and motivational properties of ethanol in miceHouchi, H. / Warnault, V. / Barbier, E. / Dubois, C. / Pierrefiche, O. / Daoust, M. / Naassila, M. et al. | 2008
- S224
-
P.1.c.008 Is a dual mechanism of action better than a single one in the inhibition of nociception by antidepressants?Suciu, R. / Ardelean, M. et al. | 2008
- S225
-
P.1.c.010 Glycine-sensitive NMDA receptors positively regulate proliferative activity in neural progenitor cellsOgita, K. / Gotoh, Y. / Yoneyama, M. et al. | 2008
- S226
-
P.1.c.012 Modulators of inhibitory synaptic transmission in mouse somatosensory cortexKruglikov, I. / Rudy, B. et al. | 2008
- S227
-
P.1.c.014 Recruitment of a bicarbonate transporter in the modulation of glutamatergic transmission in hippocampusFedirko, N. / Chesler, M. et al. | 2008
- S228
-
P.1.c.015 1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes behavioral and neurochemical effects produced by MK-801 in ratAntkiewicz-Michaluk, L. / Romanska, I. / Michaluk, J. et al. | 2008
- S229
-
P.1.c.017 Relationship between plasma and brain pharmacokinetic profiles of eslicarbazepine acetate metabolites in miceAlves, G. / Falcao, A. / Figueiredo, I. / Castel-Branco, M. / Caramona, M. / Soares-da-Silva, P. et al. | 2008
- S230
-
P.1.c.019 Regulation of pro-apoptotic Fas/FADD protein complex in brain regions of CB1-receptor deficient miceAlvaro-Bartolome, M. / Esteban, S. / Valverde, O. / Garcia-Sevilla, J. A. et al. | 2008
- S232
-
P.1.c.022 Pharmacological characterization of ghrelin receptor in rat adenoma anterior pituitary cell line, RC-4B/CPerdona, E. / Faggioni, F. / Corti, C. / Cavanni, C. et al. | 2008
- S233
-
P.1.c.024 Intra-basolateral amygdala nitric oxide inhibitor prevents prepulse inhibition disruption induced by dopamine agonistsSalum, C. / Issy, A. C. / Brandao, M. L. / Guimaraes, F. S. / Del Bel, E. A. et al. | 2008
- S234
-
P.1.c.026 Effect of mood stabilizers on the Akt/GSK-3b signaling pathway and on cell survival and proliferationAubry, J. M. / Schwald, M. / Ballmann, E. / Karege, F. et al. | 2008
- S235
-
P.1.c.028 Long-acting injectable form of antipsychotic drug risperidone based upon microspheres of polyhydroxyalkanoatesBonartsev, A. P. / Iordanskii, A. L. / Bonartseva, G. A. / Brusov, O. S. et al. | 2008
- S237
-
P.1.c.031 Lower thalamic myo-inositol level in schizophrenic patients with better cognitive outcomeSzulc, A. / Galinska, B. / Tarasow, E. / Dzienis, W. / Kubas, B. / Konarzewska, B. / Poplawska, R. / Czernikiewicz, A. / Walecki, J. et al. | 2008
- S238
-
P.1.c.033 Milnacipran reduces stress-induced ultrasonic vocalisations in rats, without impairing attention in the 5-choice serial reaction time testBardin, L. / Auclair, A. / Newman-Tancredi, A. / Depoortere, R. et al. | 2008
- S239
-
P.1.c.035 The role of nitric oxide in PC12 cells death. Protective effect of 12-lipoxygenase and cyclooxygenases inhibitorsPytlowany, M. / Cakala, M. / Strosznajder, P. R. / Jesko, H. / Strosznajder, J. B. et al. | 2008
- S240
-
P.1.c.037 Surinabant inhibits the effects of delta 9-tetrahydrocannabinol in a novel tetrahydrocannabinol-challenge testKlumpers, L. / Roy, C. / Poitiers, F. / Turpault, S. / van Gerven, J. M. et al. | 2008
- S241
-
P.1.c.039 Concomitant blockade of 5-HT1a receptor and 5-HT transporter: use of Hunter serotonin toxicity criteria in a clinical pharmacology studyParks, V. / Chalon, S. / Raje, S. / Plotka, A. / Philip, A. / Olivier, N. et al. | 2008
- S242
-
P.1.c.041 Manganese influence on morphine-induced conditioned place preference in ratsCiubotariu, D. / Chelarescu, I. / Stoica, B. / Nechifor, M. et al. | 2008
- S243
-
P.1.c.042 D3 receptor involvement in neurotrophic effects of amphetamine and cocaine on mesencephalic dopaminergic neuronsCollo, G. / Gregorini, A. / Missale, C. / Spano, P. F. et al. | 2008
- S244
-
P.1.c.044 Effects of acute flibanserin on FDG-PET brain glucose metabolism in men with major depressive disorderKonarski, J. Z. / Pyke, R. / Wunderlich, G. / Kennedy, S. H. et al. | 2008
- S245
-
P.1.c.046 Tianeptine attenuates the staurosporine- and doxorubicin-induced apoptosis in primary cortical neuronsJantas, D. / Lason, W. et al. | 2008
- S247
-
P.1.c.049 Alertness and electrocortical activity after (co-)administration of MDMA and THC in healthy volunteersLansbergen, M. M. / Dumont, G. J. / Buitelaar, J. K. / van Gerven, J. M. / Verkes, R. J. et al. | 2008
- S248
-
P.1.c.051 Effects of lamotrigine, topiramate and riluzole exerted upon pilocarpine-induced seizures in rodentsTurski, W. A. / Czuczwar, M. / Kis, J. / Nieoczym, D. / Zgrajka, W. / Brzana, W. / Wlaz, P. et al. | 2008
- S249
-
P.1.d.002 The effect of chlordiazepoxide on reward reduction-induced decrease of operant performanceNikiforuk, A. / Popik, P. et al. | 2008
- S251
-
P.1.d.005 The effects of topiramate on spatial memory and movement co-ordination in ratsNowakowska, E. / Kus, K. / Czubak, A. / Jedrzejewska, J. et al. | 2008
- S252
-
P.1.d.007 Direct and indirect modulation of cannabinoid system in psychotic-like symptoms and cognitive deficit induced by phencyclidine (PCP)Guidali, C. / Vigano, D. / Rubino, T. / Parolaro, D. et al. | 2008
- S253
-
P.1.d.009 Asenapine: a translational analysis of receptor occupancy in human and rat brain with therapeutic implicationsHenry, B. / Grimwood, S. / de Greef, R. / Shahid, M. et al. | 2008
- S254
-
P.1.d.011 Phosphonate analogue of ketoglutarate increases activity of ketoglutarate dehydrogenasecomplex in situ and in vivoTrofimova, L. K. / Graf, A. V. / Klimuk, E. I. / Kabysheva, M. S. / Sokolova, N. A. / Bunik, V. I. et al. | 2008
- S256
-
P.1.d.014 Neurochemical alterations in an environmental animal model of schizophrenia: strain related differencesCastrignano, S. / Colaianna, M. / De Giorgi, A. / Schiavone, S. / Zotti, M. / Trabace, L. et al. | 2008
- S257
-
P.1.d.016 Olfactory perception test is necessary in sociobiobehavioral researchesAmikishieva, A. / Semendyaeva, S. et al. | 2008
- S258
-
P.1.d.018 Quantitative EEG in ketamine model of psychosisPalenicek, T. / Kutova, M. / Fujakova, M. / Bubenikova-Valesova, V. / Brunovsky, M. / Horacek, M. et al. | 2008
- S260
-
P.1.e.003 Regional binding potentials of [11C]mirtazapine enantiomers in human brainSmith, D. / Hansen, S. B. / Jakobsen, S. / Bender, D. / Audrain, H. / Askhanian, M. / Stork, B. S. / Rosenberg, R. et al. | 2008
- S261
-
P.1.e.005 Serotonergic genes and amygdala activity in response to negative affective facial stimuliHam, B. / Lee, B. et al. | 2008
- S262
-
P.1.e.007 Effect of sertraline treatment on regional cerebral blood flow in obsessive compulsive disorderEbrinc, S. / Sahan, A. / Semiz, U. B. / Basoglu, C. / Ates, A. / Algul, A. / Cetin, M. et al. | 2008
- S263
-
P.1.e.008 Eszopiclone reverses brain hyperarousal in insomnia patients: evidence from [18F]-FDG PETNofzinger, E. / Buysse, D. J. / Moul, D. / Hall, M. / Germain, A. / Price, J. et al. | 2008
- S264
-
P.1.e.010 The investigation of orbitofrontal cortex and amygdala association in depressed patients by structural equation modelingZengin, B. / Ozan, E. / Kitis, O. / Eker, C. / Eker, O. / Gonul, A. S. et al. | 2008
- S266
-
P.1.e.013 In PET test-retest reproducibility of serotonin transporter binding correlates with the regional binding potentialMoser, U. / Lanzenberger, R. / Haeusler, D. / Fink, M. / Spindelegger, C. / Mitterhauser, M. / Wadsak, W. / Akimova, E. / Kletter, K. / Kasper, S. et al. | 2008
- S267
-
P.1.e.015 Frontal serotonin-1A receptor distribution is associated with aggression scores in healthy subjectsWitte, A. V. / Floel, A. / Stein, P. / Savli, M. / Hahn, A. / Fink, M. / Mitterhauser, M. / Wadsak, W. / Kasper, S. / Lanzenberger, R. et al. | 2008
- S268
-
P.1.e.016 Anatomical abnormalities of the anterior cingulate cortex before the onset of psychosisFornito, A. / Yung, A. R. / Wood, S. J. / Phillips, L. J. / Nelson, B. / Cotton, S. / Velakoulis, D. / McGorry, P. D. / Pantelis, C. / Yucel, M. et al. | 2008
- S269
-
P.1.e.018 Hypoperfusion and reduced blood-oxygen level dependent activation of the fusiform face area patients with delusional misidentification syndromeMuller, T. / Federspiel, A. / Bianchi, P. / Horn, H. / Wirth, M. / Walther, S. / Wiest, R. / Strik, W. et al. | 2008
- S270
-
P.1.e.020 Effects of cannabis ingredients in the temporal cortex - neural basis for potential antipsychotic effect of cannabidiolBhattacharyya, S. / Fusar-Poli, P. / Borgwardt, S. / Martin-Santos, R. / OCarroll, C. / Seal, M. / Crippa, J. A. / Atakan, Z. / McGuire, P. K. et al. | 2008
- S271
-
P.1.f.001 Developmental vitamin D deficiency in the rat induces a sexually dimorphic delayed onset in sensitivity to MK-801Kesby, J. / OLoan, J. C. / McGrath, J. J. / Eyles, D. W. / Burne, T. H. et al. | 2008
- S272
-
P.1.f.003 Plasma BDNF concentration in somatization disorder and its relation with clinical characteristicsHwang, I. K. / Chung, S. K. / Chung, Y. C. / Park, T. W. / Yang, J. C. / Kim, Y. K. et al. | 2008
- S274
-
P.1.g.003 Modafinil and caffeine reversal on daytime sleepiness and cognitive dysfunction induced by sleep deprivationWang, S. K. / Kim, J. L. / Chee, I. S. / Ku, M. R. et al. | 2008
- S275
-
P.1.g.005 Improving metabolic health outcomes in mentally ill populations with the Mieux-Etre Wellness programShriqui, C. / Lachance, I. et al. | 2008
- S276
-
P.1.g.007 Some aspects concerning the interaction between the cholinergic and noradrenergic systems in memory processes in ratsCiobica, A. / Hritcu, L. / Artenie, V. / Padurariu, M. et al. | 2008
- S277
-
P.1.g.008 Association between a cannabinoid receptor gene (CNR1) polymorphism and the auditory event-related P300 potentialRoser, P. / Stadelmann, A. M. / Arning, L. / Gallinat, J. / Epplen, J. T. / Juckel, G. et al. | 2008
- S278
-
P.1.g.010 Oxidative stress damage of hippocampus induced memory impairment in ratsPadurariu, M. / Hritcu, L. / Ciobica, A. / Artenie, V. et al. | 2008
- S280
-
P.1.g.013 The longitudinal prospective structure of common mental disorders during adolescence and early adulthoodGloster, A. T. / Klotsche, J. / Hoefler, M. / Beesdo, K. / Lieb, R. / Wittchen, H. U. et al. | 2008
- S281
-
P.1.g.015 Differential effects of personality trait on facial expression recognition. An repetitive TMS investigationDi Simplicio, M. / Falzarano, V. / De Capua, A. / Rossi, S. et al. | 2008
- S283
-
P.1.g.018 Cognitive performance in adolescents with anorexia nervosa: subgroups in relation to neuropsychological impairmentPerpina, S. A. / Lozano P, E. / Navarro, O. P. / Miguel, S. L. / Garcia, L. L. / Castro-fornieles, J. et al. | 2008
- S284
-
P.1.g.020 Mental health in inward patients with polycystic ovarian syndromeMusiol, M. / Kowalczyk, R. / Skrzypulec, V. et al. | 2008
- S286
-
P.1.h.002 The effects of race and other factors on diagnosis in psychiatric inpatients: a retrospective chart reviewChoi, M. / Yoo, T. / Wood, C. / Yun, Y. et al. | 2008
- S287
-
P.1.h.004 Change of mental health status caused by flood in a Korean village: prospective study over an eighteen-month periodMin, S. / Heo, J. / Go, S. / Kim, M. / Park, K. / Shin, J. et al. | 2008
- S288
-
P.1.i.002 Ca2+ buffering by mitochondria - key mechanism for modulation of store-operated Ca2+ entry induced by neurotransmittersKopach, O. / Kruglikov, I. / Voitenko, N. / Fedirko, N. et al. | 2008
- S290
-
P.1.i.005 Differential BDNF levels in a genetic rat model of depressionPlougmann, P. / Wegener, G. / Rosenberg, R. / Elfving, B. et al. | 2008
- S291
-
P.1.i.007 Differential brain, but not serum vascular endothelial growth factor levels in a genetic rat model of depressionElfving, B. / Plougmann, P. H. / Rosenberg, R. / Wegener, G. et al. | 2008
- S293
-
P.2.a.002 Treatment milestones predict symptom remission over 6-month treatment of patients with major depressive disorder (MDD)Wade, A. / Schlaepfer, T. E. / Kilts, C. D. et al. | 2008
- S294
-
P.2.a.004 Use of antidepressants in older people with mental illnessCurran, S. / Byrne, A. / Wattis, J. P. et al. | 2008
- S295
-
P.2.a.006 A comparison of quality of life, anxiety and depression in patients with macular degeneration and cataract patientsHyper-Ochalik, M. / Krysta, K. / Krupka-Matuszczyk, I. / Sygut, M. et al. | 2008
- S296
-
P.2.a.008 Comparative study on the effectiveness of anti-depressing treatment between st. Johns wort and duloxetineIstikoglou, C. / Vlissides, D. / Mavreas, V. et al. | 2008
- S297
-
P.2.a.009 Pooled analysis: 2 randomised clinical trials confirms superiority of escitalopram over paroxetine in treatment of major depressive disorderKasper, S. / Baldwin, D. / Boulenger, J. P. et al. | 2008
- S298
-
P.2.a.011 Efficacy of duloxetine in painful symptoms with major depressive disorderCastano, J. / Garnier, C. / Corcoles, D. / Rodriguez, L. / Diaz, B. / Martin, L. M. / Bulbena, A. et al. | 2008
- S299
-
P.2.a.013 Outcome situations of patients, after admission at the emergency room, with suicidal attemptMinner, P. / Lorge, D. / Cornet, H. / Neu, D. / Pelc, I. / Verbanck, P. et al. | 2008
- S301
-
P.2.a.016 BDNF in plasma following electroconvulsive therapy: a pilot study in depressed patientsDel Debbio, A. / Bianchi, C. / Roncaglia, I. / Mariotti, A. / DellOsso, M. C. / Mannari, C. / Origlia, N. / Zanello, S. / Marazziti, D. / Piccinni, A. et al. | 2008
- S302
-
P.2.a.018 Comparison of depressive symptoms of major depressive disorder between elderly and non-elderly group in South KoreaJae, Y. M. / Kim, J. G. / Lee, D. S. et al. | 2008
- S303
-
P.2.a.020 Gender differences in patterns of neurocognitive impairment during the acute phase of major depressionSarosi, A. / Gonda, X. / Balogh, G. / Faludi, G. et al. | 2008
- S304
-
P.2.a.022 Psychiatric morbidity in infertility among a sample of egyptian women: the impact on treatment outcomeRadwan, D. / Ramy, H. / Khalil, A. / Mansour, M. / El-Sayed, M. / Moussa, K. H. / El-Missiry, A. et al. | 2008
- S305
-
P.2.a.024 Vagus nerve stimulation for treatment-resistant depression: open-label European study - 24-month outcomesAllen, J. et al. | 2008
- S306
-
P.2.a.025 The differences in abnormal illness behavior questionnaire between non-somatization and somatization groupJae, Y. M. / Jang, S. H. / Lee, D. S. et al. | 2008
- S307
-
P.2.a.027 Association between tryptophan hydroxylase 2 gene and the personality traits of novelty seeking and harm avoidanceNam, Y. Y. / Lee, H. S. / Cho, D. Y. / Kim, C. H. et al. | 2008
- S308
-
P.2.a.029 A possible case of venlafaxine-associated parapsoriasisErol, A. / Ermete, M. / Aydin, O. et al. | 2008
- S309
-
P.2.a.031 Serotonin syndrome resulting from coadministration of venlafaxine, and mirtazapineAtasoy, N. / Ozturk, D. / Konuk, N. et al. | 2008
- S310
-
P.2.a.033 Venlafaxine versus selective serotonin reuptake inhibitors in mixed major depression and dysthymic disorderVasiliu, D. / Vasiliu, O. / Tudor, C. / Patriche, D. / Stanescu, B. / Ojog, D. et al. | 2008
- S311
-
P.2.a.034 Plasma dehydroepiandrosterone sulphate (DHEAS) and cortisol in patients with mood disordersCamardese, G. / Mattioli, B. / Pizi, G. / Pucci, L. / Bria, P. et al. | 2008
- S312
-
P.2.a.036 Analyses of haplotypes tagging the serotonin transporter gene (SLC6A4) provide new evidence for the gene x environment model of depressionLazary, J. / Lazary, A. / Gonda, X. / Benko, A. / Molnar, E. / Papp, D. / Juhasz, G. / Bagdy, G. et al. | 2008
- S313
-
P.2.b.002 Association between two gene polymorphisms (SNPs) of tryptophan hydroxylase gene and suicidal behavior in depressive patientsYoon, H. K. / Kim, Y. K. / Lee, B. H. et al. | 2008
- S314
-
P.2.b.003 The effects of antidepressants on the progress of weight gain and in diabetic (OLETF) and non-diabetic (LETO) ratsKee, B. / Hahm, W. / Joe, K. / Kim, S. et al. | 2008
- S315
-
P.2.b.005 Anhedonic depression: an endophenotypic approachVrieze, E. / Pizzagalli, D. / Claes, S. et al. | 2008
- S316
-
P.2.b.007 The effect of sub-convulsive electrical stimulation and electroconvulsive therapy (ECT) in a rat model for depressionToth, E. / Gersner, R. / Zangen, A. et al. | 2008
- S317
-
P.2.b.009 The effect of fluvoxamine on akt-1 phosphorylation and total akt-1 protein levels by immunoblotting in PC12 neuronal cellsNakano, M. / Misono, A. / Fujiwara, K. / Yanagida, T. / Kanai, S. / Tanaka, D. / Osada, K. / Asakura, M. et al. | 2008
- S318
-
P.2.b.010 PKC blockade prevents the in vivo allosteric modulation of the 5-HT transporter induced by escitalopramHaddjeri, N. / Lambas-Senas, L. / El Mansari, M. / Zimmer, L. / Sanchez, C. / Mnie-Filali, O. et al. | 2008
- S319
-
P.2.b.012 Depressive coping style predicts the relationship between cortisol responses and stress experienceNetter, P. / Hueppe, R. / Pohl, K. et al. | 2008
- S320
-
P.2.b.014 Chronic stress in rats as model for depression: effects of citalopram on expression of TPH isoforms 1 and 2Abumaria, N. / Ribic, A. / Anacker, C. / Flugge, G. et al. | 2008
- S321
-
P.2.b.016 Effects of antidepressant treatment on the intensity dependence of auditory evoked potential componentsLinka, T. / Wiltfang, J. / Sartory, G. / Mueller, B. W. et al. | 2008
- S325
-
P.2.c.002 A heterogeneity of depression: views from dynamics of blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF)Yoshimura, R. / Nakamura, J. / Ueda, N. / Ikenouchi-Sugita, A. / Umene-Nakano, W. et al. | 2008
- S326
-
P.2.c.004 Antidepressants are associated with increased length of hypnotic use in primary careDonoghue, J. / Lader, M. et al. | 2008
- S327
-
P.2.c.006 Trazodone in the treatment of fibromyalgia: a 12 weeks open label studyMolina-Barea, R. / Calandre, E. P. / Morillas-Arques, P. / Rodriguez-Lopez, C. M. / Garcia-Leiva, J. M. / Vilchez, J. S. / Rico-Villademoros, F. et al. | 2008
- S328
-
P.2.c.008 Fading of the inhibition of CYP2D6 after paroxetine treatment discontinuationZourkova, A. / Jurica, J. / Hadasova, E. M. / Pulkrabkova, L. et al. | 2008
- S329
-
P.2.c.009 Preliminary analysis of trazodone and pregabalin association in the treatment of fibromyalgiaVilchez, J. / Morillas-Arques, P. / Rodriguez-Lopez, C. M. / Molina-Barea, R. / Garcia-Leiva, J. M. / Calandre, E. P. / Rico-Villademoros, F. et al. | 2008
- S330
-
P.2.c.011 An open study of quietiapine augmentation in treatment resistant depressionAnderson, I. / Sarsfield, A. / Haddad, P. et al. | 2008
- S331
-
P.2.c.013 Comparative efficacy of the antidepressants agomelatine, venlafaxine and sertralineKasper, S. / Lemoine, P. et al. | 2008
- S332
-
P.2.c.015 The effect of paroxetine on amygdala reactivity after emotional faces measured with fMRIRuhe, H. G. / Booij, J. / Veltman, D. J. / Reitsma, J. B. / Michel, M. C. / Schene, A. H. et al. | 2008
- S334
-
P.2.c.018 ACTH and cortisol in major depressive disorders: antidepressant responders and non-respondersJeon, Y. / Park, E. / Yi, J. et al. | 2008
- S335
-
P.2.c.020 Prospective study of pharmacogenetic polymorphisms and response to antidepressants over 8 weeks in major depressionNg, C. H. / Schweitzer, I. / Byron, K. / Singh, A. / Peh, L. H. / Tay, W. K. / Tan, C. H. / Berk, M. et al. | 2008
- S336
-
P.2.c.022 Superior antidepressant efficacy of agomelatine versus sertraline: a randomised, double-blind studyKasper, S. / Laigle, L. / Bayle, F. et al. | 2008
- S337
-
P.2.c.023 Are moclobemide trough concentrations an adequate predictor of the systemic drug exposureIgnjatovic, A. R. / Miljkovic, B. / Todorovic, D. / Timotijevic, I. / Pokrajac, M. et al. | 2008
- S338
-
P.2.c.025 Long-term treatment with agomelatine: prevention of relapse in patients with Major Depressive Disorder over 10 monthsGoodwin, G. M. / Rouillon, F. / Emsley, R. et al. | 2008
- S339
-
P.2.c.026 A new strategy of continuation pharmacotherapy in the prevention of relapse following ECT: a controlled trialYildiz, A. / Mantar, A. / Simsek, S. / Onur, E. et al. | 2008
- S340
-
P.2.c.028 Antidepressant-associated sexual dysfunction: naturalistic settingLee, C. T. / Lee, H. K. / Kweon, Y. S. / Lee, K. U. et al. | 2008
- S341
-
P.2.c.030 Sexual dysfunction in a group of depressed female patientsMihailescu, C. / Mihailescu, A. et al. | 2008
- S342
-
P.2.c.033 The efficacy of desvenlafaxine for improving functioning and quality of life measures in patients with major depressive disorderSoares, C. / Thase, M. / Kornstein, S. / Brisard, C. / Septien-Velez, L. / Germain, J. M. / Pitrosky, B. / Patroneva, A. / Jiang, Q. / Ninan, P. et al. | 2008
- S343
-
P.2.c.035 Health care utilization and costs of depressed patients treated with escitalopram versus SNRIsErder, M. H. / Wu, E. / Ben-Hamadi, R. / Beaulieu, N. / Lu, M. et al. | 2008
- S345
-
P.2.d.001 Beta-arrestin plays a major role in the mechanism of action of antidepressant drugsGolan, M. / Schreiber, G. / Avissar, S. et al. | 2008
- S346
-
P.2.d.003 Excitatory effect of the atypical antidepressant tianeptine in the rat hippocampus: in vitro studyKapus, G. / Vegh, M. / Gacsalyi, I. / Spedding, M. / Harsing, L. G. et al. | 2008
- S347
-
P.2.d.005 Stress-induced changes of neuroplastic proteins and modulation by chronic antidepressant treatmentCalabrese, F. / Molteni, R. / Racagni, G. / Riva, M. A. et al. | 2008
- S349
-
P.2.d.008 Agomelatine counteracts alteration in circadian rhythms observed in old hamstersMocaer, E. / Van Reeth, O. / Mairesse, J. / Giovine, A. / Mennuni, G. / Catalani, A. / Maccari, S. et al. | 2008
- S350
-
P.2.d.010 Relation between weight and plasma leptin levels in female during antidepressant treatmentBossini, L. / Pierantozzi, E. / Padula, L. / Di Rienzo, M. / Fagiolini, A. / Castrogiovanni, P. et al. | 2008
- S351
-
P.2.d.012 Further characterization of norquetiapine and quetiapine in rodent models of antidepressant and anxiolytic actionHudzik, T. / Zhou, J. / Brockel, B. / Sutton, E. / Maciag, C. / Grimm, S. / Zeller, Z. / Widzowski, D. et al. | 2008
- S352
-
P.2.d.013 F15599, a post-synaptic cortical preferential 5-HT1A agonist: I) functionally-selective signal transduction profileNewman-Tancredi, A. / Martel, J. C. / Buritova, J. / Lauressergues, E. / Assie, M. B. / Slot, L. B. / Cosi, C. / Heusler, P. / Cussac, D. et al. | 2008
- S353
-
P.2.d.015 Effects of antidepressants on behavioural despair in olfactory bulbectomized ratsRoman, V. / Kedves, R. / Gyertyan, I. et al. | 2008
- S354
-
P.2.d.017 Ketanzerine modulates expression of 5-HT2A/2C- and 17b-estradiol receptors mRNAs in female rats in forced swim testFedotova, J. / Losev, N. et al. | 2008
- S355
-
P.2.d.019 Proteome changes in rat hippocampus and pre-frontal/frontal cortex in Flinders rats after nortriptyline treatmentCarboni, L. / Piubelli, C. / De Luca, M. / Gruber, S. / Andersson, W. / El Khoury, A. / Mathe, A. A. / Domenici, E. et al. | 2008
- S356
-
P.2.d.021 Individual differences in the effect of a CRF1 receptor antagonist on anxiety-related behavior and corticosterone levelsHarro, J. / Mallo, T. et al. | 2008
- S357
-
P.2.d.023 In vitro pharmacological profile of doxepin, a sleep-promoting histamine H1 antagonistMansbach, R. et al. | 2008
- S358
-
P.2.d.024 Hippocampal neuroplasticity is involved in the antidepressant-like effects of 5-HT4 receptor partial agonist SL 65.0155Tamburella, A. / Micale, V. / Navarria, A. / Drago, F. et al. | 2008
- S359
-
P.2.e.001 Social adjustment during childhood and adolescence: bipolar patients outperform healthy controlsSchulze, T. G. / Georgi, A. / Schmael, C. / Schirmbeck, F. / Strohmaier, J. / Boesshenz, K. V. / Nothen, M. M. / Rietschel, M. et al. | 2008
- S360
-
P.2.e.003 Duration of untreated illness (DUI) in bipolar disorder: a naturalistic studyDellOsso, B. / Buoli, M. / Camuri, G. / Vecchi, V. / Altamura, A. C. et al. | 2008
- S361
-
P.2.e.005 Anticonvulsant treatment, B12 plasma levels and mood disordersNeroutsos, E. / Vagionis, G. / Fiste, M. et al. | 2008
- S363
-
P.2.e.008 Low serum dehydroepiandrosteronesulphate is associated with interpersonal aggression in males with Bipolar 1 disorderJohansson, A. G. / Landen, M. et al. | 2008
- S364
-
P.2.e.010 Combined antidepressant and quetiapine therapy in bipolar I mixed - an open label studyCallista, G. / Daneluzzo, E. et al. | 2008
- S365
-
P.2.e.012 Gender differencies in the treatment of severe bipolar affective and schyzoaffective disordersCobo, J. / Coronas, R. / Barbero, J. D. / Benito, N. / Perez, M. / Pujals, E. / Fuste, G. / Garcia-Pares, G. et al. | 2008
- S366
-
P.2.e.014 Are antiepileptic mood stabilizers really effective in psychotic bipolar mania?Marinkovic, D. / Totic, S. / Marjanovic, M. et al. | 2008
- S367
-
P.2.e.015 Antiepileptic mood stabilizers (carbamazepine and valproate) in acute-phase psychotic bipolar mania treatmentTotic, S. / Marinkovic, D. / Marjanovic, M. et al. | 2008
- S368
-
P.2.e.017 Anticipation in bipolar disorders: a Comparison between the two generationsYuncu, Z. / Kesebir, S. / Akdeniz, F. / Vahip, S. et al. | 2008
- S369
-
P.2.e.019 Adult attention-deficit hyperactivity disorder in bipolar disorderTamam, L. / Karakus, G. / Ozpoyraz, N. et al. | 2008
- S370
-
P.2.e.021 A systematic review of controlled clinical trials in bipolar disorderMohr, P. / Novak, T. / Cermak, J. / Rodriguez, M. et al. | 2008
- S371
-
P.2.e.023 Placebo-controlled study with acute and continuation phase of quetiapine in adults with bipolar depression (EMBOLDEN II)Young, A. / McElroy, S. / Chang, W. / Olaulsson, B. / Paulsson, B. / Brecher, M. et al. | 2008
- S373
-
P.2.g.001 Milnacipran and atomoxetine: treatment of depressive disorder with co-morbid hyperactivity disorderMartsenkovsky, I. / Martsenkovska, I. I. / Bikshaeva, Y. B. et al. | 2008
- S374
-
P.2.g.003 Type D personality and depression in Portuguese patients with acute coronary syndrome: identifying high risk groupsPrata, J. / Ramos, S. / Coelho, R. et al. | 2008
- S375
-
P.2.g.005 Occurrence of sexual dysfunction during the maintenance treatment with newer antidepressants (naturalistic study)Zourkova, A. / Novotna, J. / Vecerova, M. / Havlikova, P. / Pulkrabkova, L. et al. | 2008
- S376
-
P.2.g.007 Association of antidepressants with episodes of schizophreniaPurvina, S. / Caune, M. / Kevere, L. et al. | 2008
- S377
-
P.2.g.008 Extended release quetiapine fumarate monotherapy as maintenance treatment in patients with major depressive disorder (MDD)Datto, C. / Lam, R. W. / Lepola, U. / Sweitzer, D. / Eriksson, H. et al. | 2008
- S378
-
P.2.g.010 Psychopharmacotherapy depressive disorders of patients suffering from malignant neoplasmsTabachnikov, S. / Vasylyeva, A. / Bugaytsov, S. / Martinenko, Y. U. et al. | 2008
- S379
-
P.2.g.012 Estimation of therapeutic efficacy of magnetic fields in patients with drug-resistant depressionSobis, J. / Hese, R. / Jarzab, M. / Sieron, A. / Gorczyca, P. / Pudlo, R. / Matysiakiewicz, J. et al. | 2008
- S382
-
P.2.h.001 Both R(-)- and S(+)-citalopram attenuates neuronal apoptosis in murine cortical cell cultureNoh, J. S. / Chung, Y. K. / Eu, M. Y. et al. | 2008
- S383
-
P.2.h.003 The behavioral and cardiovascular effects of a novel partial alpha-2 adrenoceptor agonist naphthylmedetomidineVotava, M. / Hess, L. / Schreiberova, J. / Malek, J. et al. | 2008
- S384
-
P.2.h.005 Serotonin levels and lymphocyte populations in female patients with depression: a comparative studyFigueiredo, M. / Garcia, J. R. / Mota-Garcia, F. / Mota-Cardoso, R. / Cardoso, C. S. et al. | 2008
- S385
-
P.3.a.001 Schizophrenic patients with no cognitive deficits - presentation of casesKrysta, K. / Krupka-Matuszczyk, I. / Hyper-Ochalik, M. / Sygut, M. / Przybylo, J. / Klasik, A. et al. | 2008
- S386
-
P.3.a.003 Insight and outcome in schizophrenia patientsBaek, S. B. / Yang, S. J. / Choi, W. et al. | 2008
- S388
-
P.3.a.006 The effects of BDNF-COMT gene interaction on symptoms and working memory in patient with schizophreniaHan, D. H. / Park, D. B. / Joo, S. Y. / Shin, H. C. / Lee, Y. S. / Min, K. J. et al. | 2008
- S389
-
P.3.a.008 Dysfunction of autonomic nervous system activity in schizophrenia and the influence of neurolepticsKishida, I. / Fujibayashi, M. / Tanaka, S. / Ishii, C. / Ishii, N. / Kimura, T. / Moritani, T. et al. | 2008
- S390
-
P.3.a.010 Continued loss of gray matter in chronic treatment-resistant schizophreniaMitelman, S. / Canfield, E. / Schneiderman, J. / Shihabuddin, L. / Buchsbaum, M. S. et al. | 2008
- S391
-
P.3.a.011 Facial emotion recognition in schizophrenic patientsChoi, S. / Shin, C. / Kim, Y. / Jeong, S. et al. | 2008
- S392
-
P.3.a.013 The effect of depression and anxiety symptoms on the results of combined dexamethasone/corticotrophine releasing hormone test in schizophreniaLee, S. I. / Han, B. J. / Hong, S. M. / Shin, C. J. / Son, J. W. / Kim, S. K. et al. | 2008
- S393
-
P.3.a.015 Efficacy and safety of olanzapine long-acting injection for maintenance treatment of schizophreniaDetke, H. / McDonnell, D. / Kane, J. / Naber, D. / Sethuraman, G. / Lin, D. et al. | 2008
- S394
-
P.3.a.016 Depressive dimension in acute schizophrenic inpatients and its impact on clinical outcomeMauri, M. C. / Colasanti, A. / Mazzocchi, A. / Pellegrino, F. / Moliterno, D. / Rossattini, M. / Altamura, A. C. et al. | 2008
- S395
-
P.3.a.018 Changes in antisaccadic test, gain and negative symptoms in schizophrenic patients treated with glycineStrzelecki, D. / Rabe-Jablonska, J. et al. | 2008
- S396
-
P.3.a.020 Serum trace elements and glucose 6 phosphate dehydrogenase activity level in schizophreniaKaya, B. / Akdao, N. / Fadyllyoolu, E. / Unal, S. / Sayal, A. / Erdooan, H. / Emre, M. H. et al. | 2008
- S397
-
P.3.b.001 Clinical improvement in schizophrienia is associated with a normalization of elevated serum S100B and increased sRAGESteiner, J. / Bernstein, H. G. / Bogerts, B. / Wunderlich, M. T. / Keilhoff, G. et al. | 2008
- S398
-
P.3.b.003 Neurological soft signs in paranoid disorder and schizophreniaYesilyurt, S. / Ceylan, M. E. / Maner, F. / Guler, J. / Turkcan, A. / Satmis, N. et al. | 2008
- S399
-
P.3.b.005 Cannabis use and short-term evolution of homovanillic acid levels in patients with first episode schizophreniaPertegaz, I. B. / Castro-Fornieles, J. / Deulofeu, R. / de la Serna, E. / Goti, J. / Bernardo, M. et al. | 2008
- S400
-
P.3.b.006 A proton magnetic resonance spectroscopy study of the brain metabolite changes after antipsychotic treatmentSzulc, A. / Galinska, B. / Tarasow, E. / Dzienis, W. / Kubas, B. / Konarzewska, B. / Waszkiewicz, N. / Czernikiewicz, A. / Walecki, J. et al. | 2008
- S401
-
P.3.b.008 Ser9Gly variant of dopamine D3 receptor gene associated with functioning and age at onset in females but not males with schizophreniaGodlewska, B. R. / Olajossy-Hilkesberger, L. / Marmurowska-Michalowska, H. / Landowski, J. et al. | 2008
- S403
-
P.3.b.011 QTc interval in a sample of chronic schizophrenic inpatientsPaz-Silva, E. / Ramos-Rios, R. / Arrojo-Romero, M. / Bouzon-Barreiro, J. L. / Seoane-Prado, J. / Codesido-Barcala, R. / Carballal-Calvo, F. / Crespi-Armenteros, A. / Fernandez-Perez, R. / Tortajada-Bonaselt, I. et al. | 2008
- S404
-
P.3.c.001 Outcome of the sertindole cohort prospective (SCoP) study: all-cause mortalityPeuskens, J. et al. | 2008
- S405
-
P.3.c.003 Risperidone in treatment of delusional disordersZivkovic, N. / Djokic, G. / Karlicic, I. S. / Stasevic, M. et al. | 2008
- S406
-
P.3.c.004 Effects of drd3 and dat gene polymorphisms on schizophrenia and response to olanzapineSengul, C. / Erdal, M. E. / Aydin, N. / Karadag, F. / Ay, O. I. / Sengul, M. C. / Aynacioglu, S. / Herken, H. et al. | 2008
- S407
-
P.3.c.006 Cognitive function and antipsychotic treatment in chronic schizophreniaKalwa, A. / Rzewuska, M. / Borkowska, A. / Pirog-Balcerzak, A. / Luks, M. / Skalska, J. et al. | 2008
- S409
-
P.3.c.009 Effectiveness of a long-acting risperidone and psychosocial intervention for relapse prevention in schizophreniaChoi, T. K. / Kim, J. H. / Kim, T. Y. / Lee, S. H. et al. | 2008
- S410
-
P.3.c.011 A double-blind dose-response study comparing rapid acting intramuscular olanzapine and placebo in agitated schizophreniaOno, H. / Fujikoshi, S. / Oka, T. / Sugiura, M. / Takahashi, M. et al. | 2008
- S411
-
P.3.c.013 Risperidone long acting injection: 2 year outcomes in a naturalistic studyDeslandes, P. / Thomas, A. / Lewis, A. / Sewell, R. D. et al. | 2008
- S412
-
P.3.c.015 Effects of treatment with antipsychotic medications on thyroid hormone concentrationsBunevicius, R. / Steibliene, V. / Mickuviene, N. et al. | 2008
- S414
-
P.3.c.018 Clinical improvement and metabolic effects of antipsychotic drugs in schizophreniaOlszewska, K. / Rybakowski, J. et al. | 2008
- S415
-
P.3.c.020 Psychiatrists attitudes to antipsychotic depot injections (N = 102): preferences and choiceHaddad, P. M. / Chaudhry, I. B. / Husain, N. / McLaughlin, S. / Cunningham, P. / David, A. S. / Patel, M. X. et al. | 2008
- S417
-
P.3.c.023 Cannabidiol for the treatment of psychosis in Parkinsons diseaseZuardi, A. W. / Crippa, J. A. / Hallak, J. E. / Pinto, J. P. / Chagas, M. H. / Rodrigues, G. G. / Dursun, S. M. / Tumas, V. et al. | 2008
- S418
-
P.3.c.026 The questionnaire of the usage of depot injection in JapanKanazawa, T. / Tsutsumi, A. / Nishimoto, Y. / Yoneda, H. et al. | 2008
- S419
-
P.3.c.028 A pharmacogenetic investigation of risperidone and perospirone - report from kansai multicenter studyAtsushi, T. / Tetsufumi, K. / Gaku, O. / Toshio, M. / Naoki, M. / Kazuhiro, S. / Toshifumi, K. / Hiroshi, Y. / Toshihiko, K. et al. | 2008
- S420
-
P.3.c.030 Efficacy of atypicals comparing with clasical antipsychotics in first year treatment of first episode psychosisGheorghe, M. D. / Baloescu, A. / Grigorescu, G. et al. | 2008
- S421
-
P.3.c.031 Evolution of psychotic inpatients treated with long-acting injectable risperidone after 1000 days of follow-upNieto, E. / Villar, L. / Fernandez, J. / Hernandez, C. / Roman, E. / Bonet, P. et al. | 2008
- S422
-
P.3.c.033 Adiponectin as a biomarker for metabolic syndrome among patients on atypical antipsychoticsBai, Y. M. / Chen, J. Y. / Lin, C. C. / Shiung, Y. W. / Chen, T. T. / Su, T. P. et al. | 2008
- S423
-
P.3.c.035 Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychoticsKim, S. W. / Shin, I. S. / Kim, J. M. / Yang, S. J. / Yoon, J. S. / Lee, J. H. / Chung, K. H. / Yoo, J. A. / Lee, Y. H. et al. | 2008
- S424
-
P.3.c.036 Comparison of intramuscular olanzapine and haloperidol for the treatment of deliriumKim, J. J. / Lim, H. K. / Pae, C. U. / Lee, C. U. / Lee, C. / Paik, I. H. et al. | 2008
- S425
-
P.3.c.038 The effect of quetiapine on psychotic-like symptoms in borderline personality disorder. A placebo-controlled trialvan den Broek, P. J. / Penterman, B. / Hummelen, J. W. / Verkes, R. J. et al. | 2008
- S426
-
P.3.c.040 Risk of metabolic, cardiologic, and endocrinologic abnormalities in patients under long-term antipsychotic treatmentCerveri, G. / Ala, P. / Volonteri, L. / Netti, I. / Mencacci, C. et al. | 2008
- S427
-
P.3.c.042 Use of antipsychotics in psychiatric emergency departments. A prospective study from 2003 to 2006Garnier, C. / Castano, J. / Espluga, N. / Gines, J. M. / Diaz, B. / Martin, L. M. / Merino, A. / Bulbena, A. et al. | 2008
- S429
-
P.3.c.045 Management of expectations, satisfaction and well-being of psychotic patients, their families and caregivers (alliance)Ortiz, M. F. / Casares, J. R. / Meseguer, C. / Rodriguez-Morales, A. / Alonso-Escolano, D. et al. | 2008
- S430
-
P.3.c.047 The influence of the CYP2D6 polymorphism on the clinical response to aripiprazole in patients with schizophreniaPark, H. / Kim, E. / Kang, D. / Choi, J. / Yoo, K. / Jang, I. / Shin, S. / Kwon, J. et al. | 2008
- S432
-
P.3.c.050 Attitudes of psychiatrists toward long-acting injectable antipsychoticYun, G. / Kim, Y. / Kim, E. / Lim, W. / Bae, S. / Kim, S. / Park, H. et al. | 2008
- S434
-
P.3.c.053 Do early changes in triglycerides predict later changes during olanzapine treatment?Poole-Hoffmann, V. / Case, M. G. / Stauffer, V. L. / Jacobson, J. / Conley, R. et al. | 2008
- S435
-
P.3.c.055 The incidence of metabolic syndrome and its reversibility in patients with psychotic disorders followed for one yearSchorr, S. / Slooff, C. J. / Bruggeman, R. / Taxis, K. et al. | 2008
- S436
-
P.3.c.057 An evaluation of the clinical value of aripiprazole in the treatment of maniaDonoghue, J. M. et al. | 2008
- S437
-
P.3.c.059 Post-injection delirium/sedation syndrome observed with olanzapine long-acting injection: review of the first 25 eventsMcDonnell, D. / Sorsaburu, S. / Brunner, E. / Detke, H. / Andersen, S. / Bergstrom, R. / Mitchell, M. / Ogle, K. / Watson, S. / Corya, S. et al. | 2008
- S438
-
P.3.c.060 Differences in early responders/early non-responders to atypical antipsychotics on functional outcomes in schizophreniaKinon, B. / Chen, L. / Stauffer, V. L. / Ascher-Svanum, H. / Zhou, W. / Tomori, O. / Kollack-Walker, S. / Kane, J. M. / Kapur, S. et al. | 2008
- S439
-
P.3.c.062 32 weeks follow-up of effectiveness of schizophrenia treatment with olanzapineKrzystanek, M. / Krupka-Matuszczyk, I. et al. | 2008
- S440
-
P.3.c.064 Interventions in antipsychotics-treated patients with cardiometabolic risk factors or metabolic syndromeLarsen, J. / Holdrup, M. / Christensen, B. / Sigalin, C. / Nilsson, P. M. / Kolb, S. et al. | 2008
- S441
-
P.3.c.066 Adjunctive long-acting risperidone delays mood episode relapse in patients with frequently relapsing bipolar disorderAlphs, L. / Haskins, J. T. / Turkoz, I. / Turner, N. / Schreiner, A. / Macfadden, W. et al. | 2008
- S442
-
P.3.c.068 Olanzapine orodispersible vs haloperidol both associated with lorazepam in the treatment of agitationMantua, V. / Travis, M. J. / Atakan, Z. / Isaac, M. B. / Issac, M. T. / Sweeney, C. / Komeh, J. / Shaw, A. / Rucci, P. / Kerwin, R. W. et al. | 2008
- S443
-
P.3.c.069 Day 4 partial response to ziprasidone predicts later treatment response in patients with bipolar disorderPappadopulos, E. / Vieta, E. / Mandel, F. et al. | 2008
- S444
-
P.3.c.071 Epidemiological study for the evaluation of metabolic disorders in patients with schizophrenia: The METEOR StudyDe Hert, M. / Falissard, B. / Mauri, M. / Shaw, K. / Wetterling, T. et al. | 2008
- S445
-
P.3.c.073 Cabergoline in the management of prolactine-induced symptoms in patients treated with atypical neurolepticsCobo, J. / Coronas, R. / Jimenez-Palop, O. / Perez, M. / Mas, R. / Ros, L. / Garcia-Pares, G. et al. | 2008
- S447
-
P.3.c.076 Long-term effect on weight of aripiprazole-clozapine in schizophrenia patients with suboptimal response on clozapineFleischhacker, W. / Heikkinen, M. E. / Olie, J. P. / Dewaele, P. / McQuade, R. / Hennicken, D. / Kerselaers, W. / Landsberg, W. et al. | 2008
- S448
-
P.3.d.001 SSR103800, an inhibitor of the GlyT-1 reverses hyperactivity in glutamatergic but not dopaminergic models in miceBoulay, D. / Bergis, O. / Avenet, P. / Griebel, G. et al. | 2008
- S449
-
P.3.d.003 Study investigating R231857 effects on scopolamine-induced CNS impairment in healthy menLiem-Moolenaar, M. / De Boer, P. / Zoethout, R. W. / Franson, K. / Cohen, A. F. / Van Gerven, J. M. et al. | 2008
- S450
-
P.3.d.005 Differential effects of aripiprazole and haloperidol on GSK-3b-mediated signal changes in SH-SY5Y cellsKim, Y. H. / Park, S. W. / Cho, H. Y. / Choi, S. M. / Lee, J. G. et al. | 2008
- S451
-
P.3.d.006 Effects of atypical antipsychotics on excitatory synaptic transmission, and dopamine and 5-HT levels in the hippocampusKubota, T. / Ishikawa, A. / Kawamura, T. / Shou, M. / Li, X. / Jibiki, I. et al. | 2008
- S452
-
P.3.d.008 Asenapine pharmacokinetics: influence of cytochrome p450 modulators and udp-glucuronyltransferase inhibitionDogterom, P. / Hulskotte, E. / Gerrits, M. / Timmer, C. / Ad Sitsen, J. M. / de Greef, H. / Spaans, E. / Peeters, P. et al. | 2008
- S453
-
P.3.d.010 Catabolic-anabolic balance and leucocytess apoptosis in patients with schizophreniaIvanova, S. / Vyalova, N. / Semke, A. et al. | 2008
- S454
-
P.3.d.011 Immunotropic effects of atypical neuroleptics olanzapine and amisulprideLobacheva, O. A. / Vetlugina, T. P. / Semke, A. V. / Kornetova, E. G. et al. | 2008
- S455
-
P.3.d.013 Off-label use of second generation antipsychotics in psychiatric inpatients: data from the AMSP study groupKonstantinidis, A. / Kutzelnigg, A. / Moser, U. / Grohmann, R. / Jaquenoud Sirot, E. / Engel, R. / Kasper, S. et al. | 2008
- S456
-
P.3.d.015 Pharmacokinetics of RGH-188, a novel dopamine D3/D2 antagonist/partial agonist atypical antipsychotic, in rats and dogsMeszaros, G. P. / Terjeki Bolf, E. / Gemesi, L. / Kapaas, M. / Tihanyi, K. / Szombathelyi, Z. et al. | 2008
- S458
-
P.3.d.018 Effects of typical and atypical antipsychotic drugs on spatial learning and memory consolidation in normal ratFaucard, R. / Kuzmin, A. / Kuteeva, E. / Elvander-Tottie, E. / Ogren, S. O. et al. | 2008
- S459
-
P.3.d.020 Atypical neuroleptics may modify cortical oscillatory activity in schizophreniaMayner, G. / Ortuno, F. / Lopez, P. / Alegre, M. / Valencia, M. / Artieda, J. et al. | 2008
- S461
-
P.3.d.023 The effects of quetiapine and haloperidol on human plasma lipid peroxidation in vitroDietrich-Muszalska, A. / Rabe-Jablonska, J. / Kontek, B. et al. | 2008
- S462
-
P.3.e.002 Prognostic value of affective symptomatology in first-admitted psychotic patients: a three-year follow-up studyArrasate, M. / Gonzalez-Pinto, A. / Mosquera, F. / Gonzalez, C. / Aldama, A. / Ibanez, B. / Gutierrez, M. et al. | 2008
- S463
-
P.3.e.004 Neurological soft signs and frontal executive function in schizophrenics and their first degree relativesChee, I. S. / Kim, J. L. / Wang, S. K. / Hwang, B. J. et al. | 2008
- S464
-
P.3.e.005 Alert for metabolic abnormalities before initiating acute phase treatment of bipolar disorderKim, B. / Kim, S. U. / Park, H. J. / Kim, S. Y. / Kim, H. S. / Joo, Y. H. et al. | 2008
- S465
-
P.3.e.007 Polypharmacy: past or current psychiatric practiceFilovska, V. / Kujindziska, J. M. / Dimova, O. et al. | 2008
- S466
-
P.3.e.009 Gender differences in schizophrenia: study a womens sample in treatment in the communityZamarro, M. / Dolores Crespo, D. C. et al. | 2008
- S467
-
P.3.e.011 Psychotic disorders and risk for later cancer: a cohort studyWeiser, M. / Werbeloff, N. / Lubin, G. / Shmushkevitz, M. / Afek, A. / Barchana, M. / Davidson, M. et al. | 2008
- S468
-
P.3.e.013 Long-term efficacy of repetitive TMS in the treatment of negative symptoms of schizophreniaPrikryl, R. / Ustohal, L. / Kasparek, T. / Venclikova, S. / Kucerova, H. / Ceskova, E. et al. | 2008
- S470
-
P.3.e.016 Humanistic and economic outcomes associated with negative symptoms in patients with schizophreniaKleinman, L. / Mannix, S. / Leeuwenkamp, O. / Revicki, D. / Velligan, D. et al. | 2008
- S471
-
P.3.e.018 Antipsychotic preparation and schizophrenia relapse risk: a one-year survey in a naturalistic settingLeuvennink, J. C. / Hall, D. J. / Frew, K. et al. | 2008
- S472
-
P.3.e.020 Acute agitation, psychotic symptoms and use of neuroleptics: a study of pre-hospital managementTonn, P. / Reuter, S. C. / Gerlach, N. / Dahmen, N. et al. | 2008
- S474
-
P.3.f.002 CNS infections during childhood and risk for schizophrenia: a case control studyHalperin, D. / Davidson, M. / Werbeloff, N. / Yoffe, R. / Levine, A. / Livni, G. / Weiser, M. et al. | 2008
- S475
-
P.3.f.003 Dysfunctional gamma-band activity during the processing of facial structure in schizophrenia patientsLee, S. H. / Kim, E. Y. / Kim, S. R. / Park, Y. M. / Che, H. / Im, C. H. et al. | 2008
- S476
-
P.3.f.005 A2A-adenosine, D2-dopamine and CB1-cannabinoid receptors in postmortem prefrontal cortex of schizophrenicsUriguen, L. / Garcia-Fuster, M. J. / Callado, L. F. / Morentin, B. / La Harpe, R. / Casado, V. / Lluis, C. / Franco, R. / Garcia-Sevilla, J. A. / Meana, J. J. et al. | 2008
- S478
-
P.4.a.002 Psychopharmacotherapy and suicidal behaviour of patients with anxiety and stress related disordersSegrec, N. / Delic, M. / Pregelj, P. et al. | 2008
- S479
-
P.4.a.004 Remission in patients treated for generalized anxiety disorder in primary and psychiatric care: the MIRABEL studyAnsseau, M. / Sabbe, B. / Vanbelle, S. / Albert, A. / Mignon, A. et al. | 2008
- S480
-
P.4.a.006 Evaluation of the prevalence of anxiety disorders with comorbidity of depression among geriatric psychiatry outpatientsBeskardes, F. / Ertan, T. et al. | 2008
- S481
-
P.4.a.007 Contingent negative variation abnormalities in posttraumatic stress disorderPapart, P. / Ansseau, M. / Bartholome, F. et al. | 2008
- S482
-
P.4.a.009 Discrepancy between objective and subjective sleep in patients with post-traumatic stress disorder: an actigraphic studyLee, J. Y. / Shin, H. B. / Kim, S. J. / Kwon, J. W. / Lyoo, I. K. / Jeong, D. U. et al. | 2008
- S483
-
P.4.a.011 P wave changes in ECG in patients with generalized anxiety disorder and the influences of sertralineKocabasoglu, N. / Emul, M. / Kutukcu, A. / Zerdali, H. / Baser, S. / Ugur, M. / Keles, I. et al. | 2008
- S484
-
P.4.a.012 Adjunctive levetiracetam for treatment refractory post-traumatic stress disorder (PTSD)Kinrys, G. / Rothstein, E. / Oltramari, A. C. / Dunn, R. / Nery, F. / Bianco, R. et al. | 2008
- S485
-
P.4.a.014 Serum cortisol and DHEA-S levels in PTSD patients versus controls: correlations to panic-agoraphobic spectrum symptomsCarmassi, C. / Da Pozzo, E. / Martini, C. / Paggini, R. / Tonini, S. / Mundo, F. / Cesari, D. / Amendola, L. / Ciapparelli, A. / DellOsso, L. et al. | 2008
- S487
-
P.4.b.002 Effects of imipramine repeated treatment on BDNF levels in the dorsal periaqueductal gray matter and hippocampusCasarotto, P. C. / Joca, S. R. / Guimaraes, F. S. / Junior, H. Z. et al. | 2008
- S488
-
P.4.b.004 The change of heart rate variability during 6-week pharmacotherapy in patients with panic disorderKim, W. / Woo, J. M. et al. | 2008
- S489
-
P.4.b.006 Psychic and somatic anxiety symptom burden and functional remission in generalized anxiety disorderMychaskiw, M. A. / Hoffman, D. L. / Dodge, W. E. / Herman, B. K. et al. | 2008
- S491
-
P.4.b.009 Relationship of panic and agoraphobia: rethinking of a diagnostic concept?Nocon, A. / Wittchen, H. U. / Beesdo, K. / Pine, D. S. / Hofler, M. / Lieb, R. / Gloster, A. T. et al. | 2008
- S492
-
P.4.c.001 Effectiveness of the combination of citalopram and clomipramine in resistant OCD patientsConsoli, G. / Golia, F. / DellOsso, M. C. / Carlini, M. / Presta, S. / Pfanner, C. / Mungai, F. / Marazziti, D. et al. | 2008
- S494
-
P.4.c.004 Effect of escitalopram on simulated public speakingDel-Ben, C. M. / Garcia-Leal, C. / Graeff, F. G. / Leal, F. M. / Guimaraes, F. S. et al. | 2008
- S495
-
P.4.d.002 Overexpression of cannabinoid CB2 receptors results in an anxiety-resistant behavioural phenotypeGarcia-Gutierrez, M. S. / Manzanares, J. et al. | 2008
- S496
-
P.4.d.004 Anxiolytic-like effects induced by noradrenaline microinjected into the dorsal periaqueductal gray of ratsPelosi, G. G. / Resstel, L. B. / De Paula Soares, V. / Zangrossi, H. / Guimaraes, F. S. / Correa, F. M. et al. | 2008
- S497
-
P.4.e.002 The effects of acute naltrexone premedication in experimental panic provocationEsquivel, G. / Fernandez-Torre, O. / Schruers, K. / Wijnhoven, L. / Griez, E. et al. | 2008
- S498
-
P.4.e.004 Effect of repetitive TMS of the left orbitofrontal cortex in drug-resistant obsessive-compulsive patients: a controlled investigationMarino, E. / Ruffini, C. / Pirovano, A. / Locatelli, M. / Benedetti, F. / Smeraldi, E. et al. | 2008
- S499
-
P.4.e.005 Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the treatment of GADMerideth, C. / Cutler, A. / Neijber, A. / She, F. / Eriksson, H. et al. | 2008
- S500
-
P.4.f.001 Genetic dissection of motor activity levels and anxiety-related behavior in mice using an automated home cage taskde Mooij-van Malsen, J. G. / Olivier, B. / Herzhog, H. / Kas, M. J. et al. | 2008
- S501
-
P.4.f.003 Effect of stress on brain activation patterns in women with postpartum obsessive-compulsive and depressive disordersLord, C. / Hall, G. B. / Carew, C. / Soares, C. N. / Steiner, M. et al. | 2008
- S502
-
P.4.f.004 The effects of topiramate on acute anxiety models in ratsBuzoianu, A. D. / Bocsan, I. C. / Militaru, F. C. / Major, Z. et al. | 2008
- S503
-
P.5.a.001 The grading systems of the korean long-term care system in the elderly with dementia; the 2nd pilot projectHong, N. / Yeon, B. K. et al. | 2008
- S504
-
P.5.a.003 Risperidone vs. haloperidol in treatment of delirium superimposed on dementiaDjokic, G. / Zivkovic, N. / Pavicevic, D. / Lazic, D. / Djokic, K. / Marjanovic, V. et al. | 2008
- S505
-
P.5.a.005 Efficacy of cholinesterase inhibitors and memantine in Alzheimers disease: a meta-analysisKani, C. / Papanikolaou, K. / Pehlivanidis, A. / Papadopoulou-Daifoti, Z. et al. | 2008
- S507
-
P.5.a.008 Yearly longitudinal prospective healthcare costs of Alzheimer disease in routine medical practice: a Spanish perspectiveRabasa, I. / Coduras, A. / Frank, A. / Bermejo, F. / Lopez-Pousa, S. / Lopez-Arrieta, J. M. / Del Llano, J. / Leon, T. / Rejas, J. et al. | 2008
- S508
-
P.5.b.001 The implication of oxidative stress in a rat model of Parkinsons diseasePadurariu, M. / Hritcu, L. / Ciobica, A. / Artenie, V. et al. | 2008
- S509
-
P.5.b.003 Apolipoprotein E disclosure for genetic risk assessment of Alzheimers disease: preparing for pharmacogeneticsGreen, R. C. / Roberts, J. S. / Cupples, L. A. / Hiraki, S. / Obisesan, T. / Relkin, N. / Royal, C. / Whitehouse, P. et al. | 2008
- S510
-
P.5.b.004 Phospholipase A2 and phospholipase D platelet activity in patients with vascular dementiaKrzystanek, E. / Krzystanek, M. / Opala, G. / Trzeciak, H. I. et al. | 2008
- S511
-
P.5.b.006 The influence of apolipoprotein E epsilon4 allele on cognitive function in questionable dementiaMoon, S. et al. | 2008
- S512
-
P.5.c.002 An attempt of factorial analysis of the typological formation of non-psychotic disturbances due to brain damageMargaryan, S. et al. | 2008
- S514
-
P.5.d.002 Stereospecific synthesis and potential neuroprotective activity of alkaloid securinine derivativesKlochkov, S. / Shevtsova, E. F. / Afanaseva, S. V. / Neganova, M. E. / Serkova, T. P. et al. | 2008
- S515
-
P.5.e.002 Regional cerebral blood flow in patients with alcohol related dementia: a SPECT studyGo, H. J. / Chung, Y. / Choi, S. / Joe, K. / Cheon, Y. / Kim, D. et al. | 2008
- S517
-
P.5.e.005 A 12-week study of eszopiclone in elderly out-patients with primary insomnia: effects of treatment discontinuationKrystal, A. / Ancoli-Israel, S. / McCall, W. / Schaefer, K. / Claus, R. / Rubens, R. / Roth, T. et al. | 2008
- S518
-
P.5.f.001 Dietary restriction effects on age induced changes in APP, PS-1 and ADAM mRNA expressionDjordjevic, A. M. / Perovic, M. / Tanic, N. / Ruzdijic, S. / Kanazir, S. et al. | 2008
- S520
-
P.6.a.003 Is attentional bias a good measure of incentive properties of alcohol-associated stimuli in alcohol-dependent patients?Loeber, S. / Vollstaedt-Klein, S. / von der Goltz, C. / Mann, K. / Kiefer, F. et al. | 2008
- S521
-
P.6.a.005 Comparative sleep improving effects of zolpidem vs. nitrazepam at alcoholicsJakovcevska-Kujundziska, M. / Lazarova, V. / Cadikovska, N. / Filovska, V. et al. | 2008
- S522
-
P.6.a.007 Venlafaxine vs. alprazolam in the treatment of alcohol dependenceLazarova, V. / Kujundziska, M. J. / Cadikovska, N. / Filovska, V. et al. | 2008
- S523
-
P.6.a.009 Pregabalin versus naltrexone in alcohol dependence: results from a multicenter, rondomized, double-blind, comparison trialMartinotti, G. / Di Nicola, M. / Tedeschi, D. / Guglielmo, R. / Janiri, L. et al. | 2008